The Pseudomonas aeruginosa Type IV pilus-associated protein PilY1 is required for stable fiber formation and host attachment by Heiniger, Ryan William
i 
 
 
 
 
 
The Pseudomonas aeruginosa Type IV Pilus-Associated Protein PilY1 is Required for Stable Fiber 
Formation and Host Attachment 
 
 
 
Ryan William Heiniger 
 
 
 
A thesis submitted to the faculty of the University of North Carolina at Chapel Hill in the partial 
fulfillment of the requirements for the degree of Master of Science in the Department of 
Microbiology and Immunology. 
 
 
 
Chapel Hill 
2009 
 
Approved by: 
 
Advisor:  Dr. Matthew Wolfgang 
 
Reader:  Dr. Tom Kawula 
 
Reader:  Dr. Robert Bourret 
 
Reader:  Dr. Janne Cannon 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2009 
Ryan William Heiniger 
ALL RIGHTS RESERVED 
 
iii 
 
 
 
 
 
 
 
ABSTRACT 
 
RYA WILLIAM HEIIGER: The Pseudomonas aeruginosa Type IV Pilus-Associated 
Protein PilY1 is Required for Stable Fiber Formation and Host Attachment  
 
(Under the direction of Dr. Matthew Wolfgang) 
 
Pseudomonas aeruginosa is an opportunistic bacterial pathogen that is a leading cause of hospital-
acquired pneumonia and the primary pathogen associated with chronic respiratory infection in 
individuals with cystic fibrosis (CF).  P. aeruginosa pathogenesis involves a wide variety of virulence 
factors; including secreted toxins, Type II and type III secretion systems, quorum sensing, biofilms, 
flagellum, and Type IV pili (TFP).  TFP are long surface fibers composed primarily of pilin subunits, 
and are known to function in both a specialized form of movement known as twitching motility and 
attachment to host cells and tissues.  An exposed epitope on the terminal pilin subunit of TFP is 
believed to mediate P. aeruginosa binding to host glycosphingolipids.  We hypothesized that PilY1, a 
putative minor pilus-associated protein, may play a direct role in TFP-dependent bacterial adherence 
due to its homology to a known TFP-associated adhesin in eisseria gonorrhoeae, PilC. We 
confirmed a previous report that pilY1 is required for pilus biogenesis, though this requirement is 
dependant on the presence of PilT.  We demonstrated PilY1 is required for adherence to injured 
Human Airway Epithelial (HAE) cells, indicating a potential role as a TFP-associated adhesin. This 
adherence requires the association of PilY1 with surface TFP fibers, a process that involves a set of 
pilin-like proteins (FimU, PilV, PilW, PilX, and PilE). Overall, our results indicate that adherence of 
P. aeruginosa to host cell requires both TFP and PilY1 and that PilY1 is a bi-functional protein with 
distinct roles in TFP biogenesis and adherence. 
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CHAPTER 1 
 
 
ITRODUCTIO 
 
 
 
Pseudomonas aeruginosa is a gram-negative opportunistic pathogen, capable of causing a 
variety of life threatening infections in immunocompromised individuals (61).  Recent statistics 
indicate that P. aeruginosa is responsible for greater than 10% of all hospital-acquired infections and 
nearly 22% of infections acquired in intensive care units (54).  In addition, P. aeruginosa causes 
chronic lung infections in individuals with cystic fibrosis (CF), resulting in significant morbidity and 
mortality (78). Efforts to treat P. aeruginosa infections are hampered by the bacterium’s high intrinsic 
antibiotic resistance and its ability to develop further resistance during antibiotic therapy (29).  A 
unique feature of this organism is its versatility.  P. aeruginosa can thrive in a wide range of natural 
environments (85) and can utilize over 50 different carbon sources (239). In aqueous environments, 
P. aeruginosa is highly motile; however, it can display complex multicellular phenotypes including 
the ability to form biofilms on a variety of biological and abiotic surfaces (39, 124).  While P. 
aeruginosa is considered to be a strict aerobe, it can grow under hypoxic conditions using 
nitrite/nitrate as terminal electron acceptors (81).  In addition to its metabolic and physiological 
flexibility, P. aeruginosa produces an abundance of surface associated and secreted virulence factors 
(129, 159), which allow it to infect many eukaryotic organisms such as plants, nematodes, insects and 
humans (43, 190, 196).  
The ability of P. aeruginosa to inhabit diverse environments and cause disease in a variety of 
hosts is due in part to its relatively large and dynamic genome. To date, the genomes of five P. 
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aeruginosa strains have been determined (126, 144, 224). The genome of P. aeruginosa strains can 
vary between 6-7 million bases and is on average about 50% larger than the Escherichia coli genome. 
The genome of P. aeruginosa strain PAO1 is 6.3 million base pairs and contains 5,570 predicted open 
reading frames (ORFs).  Moreover, the P. aeruginosa genome contains a high proportion of 
regulatory genes (8.4% of predicted ORFs) which is presumed to contribute to its adaptability, broad 
host range and high intrinsic resistance to a wide range of antimicrobial substances (79, 121, 224).  In 
comparison, only around 5% of the genes in E. coli and Bacillus subtilis are regulatory genes (224).  
The pathogenic potential of this versatile bacterium is also reflected by the high number of genes 
encoding secreted virulence factors such as toxins and tissue degrading enzymes including proteases 
and phospholipases (224).  Despite the large size of the P. aeruginosa genome, its core gene content 
appears to be relatively stable (254). Greater than 95% of the genes in strain PAO1 are found in 
strains collected from diverse habitats and various human infections. The conservation of a large 
genome may provide P. aeruginosa with the capacity to inhabit a wide range of environments. 
However, the ability of P. aeruginosa to further adapt and thrive in different or new environments 
depends on the ability of individual strains to acquire large novel genomic segments (144).  These 
genomic segments can also play key roles in the infection process itself (250).   
While P. aeruginosa is able to grow and survive in almost any environment, it rarely causes 
infections in healthy individuals.  To initiate infection, P. aeruginosa often requires a substantial 
break in first-line host defenses.  This usually involves a breach or bypass of normal cutaneous or 
mucosal barriers (trauma, surgery, or serious burns), disruption of the protective balance of normal 
mucosal flora by broad spectrum antibiotics, or alteration of the immune system (chemotherapy or 
CF).  Once P. aeruginosa breaches these defenses, it can colonize the altered or damaged epithelium.  
Initial colonization requires the expression of bacterial surface fibers termed Type IV pili (TFP), 
which serve as an adhesin for host cells and tissue (51).  Following colonization, P. aeruginosa can 
undergo transcriptional and mutational adaptation to the host environment facilitating either acute or 
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chronic infection.  Acute infections are characterized by the production of numerous extracellular 
virulence factors.  These factors (described in detail below) contribute to tissue damage, immune 
evasion, dissemination to the blood stream and peripheral organs, and frequently death.  In contrast, 
chronic infection is characterized by mutational adaptations that lead to the production of an alginate 
capsular polysaccharide, biofilm formation, and reduced production or the loss of surface attached 
and secreted virulence factors. In chronic infections, tissue damage and disease progress is primarily 
due to unrelenting and non-productive inflammation.  Overall, the pathogenesis of Pseudomonas 
aeruginosa infections is multifactorial due to the wide array of virulence factors possessed by the 
bacterium.  This is to be expected given the wide range of diseases caused by P. aeruginosa; 
including septicemia, urinary tract infections, pneumonia, chronic lung infections, endocarditis, and 
dermatitis. 
Acute Infections 
Over the last few decades, P. aeruginosa has emerged as a major opportunistic human 
pathogen accounting for a high number of hospital-acquired infections, especially in intensive care 
units (138, 202).  P. aeruginosa is responsible for 12% of hospital-acquired urinary tract infections, 
8% of surgical wound infections, 10% of bloodstream infections, and 16% of nosocomial pneumonia 
cases (77).  This bacterium often infects decubitus ulcers and burn wounds, thereby retarding healing 
or even causing enlargement of the wounds (42).  P. aeruginosa infections are also commonly found 
among immune suppressed individuals such as AIDS patients or cancer patients undergoing 
chemotherapy.   
Our current understanding of the pathogenesis of acute P. aeruginosa infection relies heavily 
on studies using animal infection models of pneumonia. Based on these studies, the picture of P. 
aeruginosa pathogenesis is complex, producing a result that depends on the multiple virulence factors 
displayed by the bacteria, as well as the host response.  P. aeruginosa expresses both a flagellum and 
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polar TFP during its initial stage of infection.  Flagella are critical for motility of the bacterium to the 
site of infection; however flagellin, the major structural subunit of the flagellum, is a potent pro-
inflammatory signaling molecule that is detected by host toll-like receptor 5 (TLR5) (60).  In fact, the 
proinflammatory role of flagellin has been shown to be a major factor in early death in a mouse 
model of acute pneumonia (10).  Polar type IV pili play a crucial role in attachment of the bacteria to 
host epithelial cells (51), and may play a role in translocation of P. aeruginosa to tissue beyond the 
initial infection site via a specialized form of TFP-dependent movement known as twitching motility 
(1).   
Once attached to lung epithelial cells, the P. aeruginosa type III secretion system can be 
activated, a process requiring type IV pilus mediated adherence (60, 83).  The type III secretion 
system directly injects a set of effector proteins (ExoS, ExoT, ExoU, and ExoY) into the host cell. 
Following delivery to the host cell cytoplasm, the effector proteins can disrupt a variety of cellular 
processes and promote invasion of P. aeruginosa into the underlying tissue.  Direct injection of ExoU 
has been shown to cause irreversible damage to cellular membranes and rapid necrotic death (203), 
while ExoS and ExoT disrupt cellular processes; including cell division, phagocytosis, and cell 
migration, by disrupting the actin cytoskeleton (57).  Secretion of type III effector proteins can also 
act on immune cells to promote immune evasion.  In human infections and mouse models of 
pneumonia, ExoU may specifically target and kill neutrophils, leading to localized areas of immune 
suppression (49, 56).  This effector protein can also inhibit caspase-1-mediated pro-inflammatory 
cytokine production (228).  Additionally, both ExoS and ExoT are known to inhibit cell migration, 
wound healing, and bacterial uptake by macrophages and neutrophils (72, 187). 
The importance of type III secretion in P. aeruginosa virulence has been demonstrated in 
mouse models of infection.  Intravenous administration of polyclonal antibodies against PcrV, a 
protein involved in translocation of type III secretion effector proteins from P. aeruginosa, resulted in 
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complete survival of the mice (210).  Similar studies in a rabbit model of P. aeruginosa-induced 
septic shock showed that treatment with anti-PcrV IgG significantly reduced lung injury, bacteremia, 
and plasma TNF-α levels compared to animals treated with control IgG (210).  Finally, in a human 
study, the relative risk of mortality was six-fold higher in acute infections involving P. aeruginosa 
strains that possessed a functional type III secretion system (82).  
In addition to type III secretion and the associated effector molecules, P. aeruginosa 
expresses many other virulence factors that contribute to its pathogenicity in acute infections.  
Quorum sensing (QS) systems control a variety of virulence factors (71, 123, 177), and the associated 
quorum sensing molecules have the potential to directly modulate the immune system by inducing 
apoptosis of neutrophils and macrophages (230).  These molecules are also known to increase the 
production of proinflammatory cytokines from airway epithelial cells and macrophages (215, 217, 
231).  Factors such as pili, flagella, and surface polysaccharides are involved in bacterial colonization, 
while factors such as elastase, alkaline proteases, hemolysins (phospholipase and lecithinase), and 
cytotoxins promote tissue invasion by P. aeruginosa.  The elastases disrupt the integrity of the 
epithelial barrier by disrupting epithelial cell tight junctions and interfering with mucociliary 
clearance (141), while exotoxin A inhibits protein synthesis and promotes host cell death by 
catalyzing the ADP-ribosylation of eukaryotic elongation factor-2 (14, 260).  Exotoxin A, in 
particular, is a potent virulence factor capable of being highly lethal in animal models of infection, 
and correlates with survival in studies of patients with P. aeruginosa sepsis (117, 118).  All of these 
factors, as well as their role in P. aeruginosa infection, will be described in detail later in this 
introduction. 
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Chronic Infections 
In general, acute P. aeruginosa infections develop rapidly, involve substantial inflammation, 
and if untreated lead quickly to sepsis and death. In contrast, chronic infections are characterized by a 
slower rate of disease progression.  Early in the development of chronic infection, patients can be 
culture positive for P. aeruginosa without any obvious impact on health, and then gradually the 
clinical condition deteriorates as the infection persists (95).  Early in chronic infections, P. aeruginosa 
strains appear to possess a full complement of virulence factors; however, eventually many of these 
factors including, flagella, type III secretion and TFP are lost due to mutation (94, 151, 216).  It is 
generally believed that these “acute” virulence factors are not required once a chronic infection has 
been established and that they are counterproductive given their ability to be recognized by both the 
innate and adaptive immune systems (214).  The best characterized chronic infection caused by P. 
aeruginosa occurs in cystic fibrosis (CF) patients, where P. aeruginosa is the main source of 
morbidity and mortality due to lung failure caused by prolonged P. aeruginosa infection (96, 112, 
133).  
CF is an autosomal recessive disease and according to Centers for Disease Control and 
Prevention (CDC), the incidence rate is 1:3300 among non-Hispanic Caucasians and 1:9000 and 
1:15,300 among Hispanic Caucasians and African Americans, respectively (133).  The disease is 
caused by dysfunction of a cAMP-regulated chloride channel, CFTR (Cystic Fibrosis Transmembrane 
Conductance Regulator) and more than 1500 different mutations have been identified in the CFTR 
gene.  CFTR is localized to the apical plasma membrane of epithelia cells including those located in 
the respiratory, gastrointestinal, hepatobiliary and reproductive systems where it is involved in 
electrolyte secretion and absorption across the epithelium.  As the name implies the CFTR protein is a 
“conductance regulator” and thereby it affects many important transport systems involved in the 
maintenance of the basal state fluid balance.  Inactivating mutations in the CFTR gene result in an 
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increased resorption and a decreased secretion of water, which among other serious effects leads to 
dehydration of mucosal surfaces. Reduced surface liquid volume in the airways of CF patients 
impairs ciliary function thereby reducing mucociliary clearance and creating the basis for recurrent 
infections (133).  In young CF patients a variety of bacteria such as Haemophilus influenzae, 
Staphylococcus aureus and Streptococcus pneumonia cause pulmonary infections.  From the age 10-
14, P. aeruginosa becomes the predominant pathogen in the CF lung, sometimes followed by co-
infection by Burkholderia cepacia (64). 
In order to adapt to environments like the CF lung, P. aeruginosa can coordinately express a 
variety of genes in a bacterial cell/density-dependent manner. This response is controlled by quorum 
sensing systems, which are complex regulatory circuits involving cell-to-cell signaling (46, 177).  
This type of signaling allows for gene regulation in response to bacterial density through the 
production of small, diffusible autoinducers known as homoserine lactones (HSLs) (68).  These 
molecules are secreted, accumulate in the external environment, and upon reaching a critical 
concentration, are sensed by the bacteria, triggering various responses.  One such response is the 
formation of biofilms.  Activation of quorum sensing cascades promotes formation of biofilms, which 
can make conditions more favorable for survival in the “thickened” mucus environment of the CF 
lung (23).  Beyond survival due to conditions within the lung, biofilms can also contribute 
significantly to the resistance of P. aeruginosa to aggressive antimicrobial therapy (222).  While 
technical difficulties exist in studying the contribution of biofilms to pathogenesis within the CF lung, 
studies have shown the presence of quorum sensing molecules in CF sputum, which has been used as 
evidence that P. aeruginosa forms biofilms in the CF lung (213).  Further, treatment with 
azithromycin, which interferes with quorum sensing signaling and alginate production (described 
below), helps clear P. aeruginosa from a mouse model of chronic lung infection (92). 
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  The most prominent feature of P. aeruginosa infecting CF patients is its conversion to a 
mucoid phenotype, where it overproduces the exopolysaccharide alginate (78).  Mucoid strains of P. 
aeruginosa have been associated with the establishment of the chronic phase of respiratory infections 
in CF (133), protection from phagocytosis (208), and protection from reactive oxygen intermediates 
(125, 212).  Further, alginate overproduction has been shown to improve the resistance of P. 
aeruginosa to the innate clearance mechanisms in the lung of a mouse model of respiratory infection 
(22).  
Other factors besides reduced bacterial clearing caused by high mucus viscosity and 
overproduction of alginate might predispose CF patients to chronic bacterial colonization.  It has been 
proposed that CFTR functions as an epithelial cell receptor for P. aeruginosa being involved in 
bacterial internalization and clearance from the lung.  The absence of apical CFTR in CF patients may 
be a critical factor for the hypersusceptibility of these patients to P. aeruginosa chronic lung 
infections (188, 189).  The increased bacterial survival in the CF lung may in part be caused by 
impaired phagocytic killing by neutrophils due to the elevated chloride concentration (229).  Finally, 
the ability of P. aeruginosa to grow anaerobically may be an important determinant in its ability to 
cause a chronic infection within the CF lung.  P. aeruginosa CF lung infections are often modeled 
under aerobic laboratory conditions.  However, direct oxygen measurements within the CF lung 
sputum in situ indicated that sputum contains hypoxic and potentially anaerobic regions (255).  
Additionally, strict anaerobic bacteria have been detected in sputum samples from multiple CF 
patients, suggesting that an environment capable of sustaining these species is present in vivo (104, 
197, 235).  The presence of antibodies to components of two putative anaerobic nitrate reductases of 
P. aeruginosa in sera of CF patients (15), suggests that the ability of P. aeruginosa to grow 
anaerobically may be an important adaptation during chronic CF infections.  Beyond factors 
important in acute or chronic infections, there is another aspect of P. aeruginosa that plays an 
important role in general virulence; antibiotic resistance.   
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Antibiotic Resistance 
P. aeruginosa has an intrinsic high resistance against most antibiotics, which significantly 
contributes to eradication failure, especially in patients with CF.  Different mechanisms accounts for 
this inherent multi-drug resistance against a range of structurally and functionally different antibiotics 
such as chloramphenicol, kanamycin, imipenem, tetracycline and many dyes (113, 114, 152, 194). 
First, the permeability of the P. aeruginosa cell membrane is 10 to 100 fold lower than for 
other gram-negative bacteria, and this protects it from harmful substances entering the cell (161).  
Other important factors adding to P. aeruginosa’s ability to tolerate high doses of antibiotics are the 
constitutively expressed multidrug efflux pumps such as MexAB-OprM and Mex pumps induced by 
the presence of antibiotics such as MexXY–OprM, MexCD–OprJ and MexEF–OprN (161, 191).  
Efflux is usually not considered to confer high levels of resistance, but it may narrow the choice 
antibiotics in the clinic (131).  Induced efflux of antibiotics may also favor the emergence of target-
specific mutations due to lowered intra-bacterial antibiotic concentrations (160).  Predictions based on 
the sequenced PAO1 genome suggest that there may be as many as 30 efflux systems in P. 
aeruginosa (224).  
In addition to efflux mechanisms, many clinical strains of P. aeruginosa produce enzymes 
that target the activity of antibiotics such as β-lactamase and aminoglycoside acetyltransferase (47).  
P. aeruginosa can also develop high-level resistance by altering the targets of antibiotics. A number 
of clinical strains have acquired a novel enzyme that can methylate the 16S rRNA subunit, resulting 
in resistance to various aminoglycosides that inhibit protein synthesis (50). Furthermore, P. 
aeruginosa frequently develops high-level resistance to fluoroquinolones by acquiring mutation in 
genes encoding its targets (DNA gyrase and the topoisomerase IV) (119, 158, 261). 
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While antibiotic resistance is a major roadblock in the treatment of P. aeruginosa infections, 
relatively few novel antibiotics with antipseudomonal activity are currently being developed (74, 
152).  This is troubling, as infections caused by resistant strains are associated with a three-fold 
higher rate of mortality, a nine-fold higher rate of secondary bacteremia, and a two-fold increase in 
the length of hospital stay (74).  Thus, besides the personal consequences for the patients, resistant 
strains also considerably increase healthcare costs.  Unfortunately it seems that the frequencies of 
multidrug-resistant P. aeruginosa (defined as resistance to at least three main classes of 
antipseudomonal agents such as β-lactams, carbapenems, aminoglycosides and fluoroquinolones) are 
increasing worldwide, reaching frequencies of up to 20 % in intensive care units in the USA and 
above 30 % in Asia (149, 152, 167).  As such, the development of new therapeutic strategies, 
including drugs acting on new targets is urgently needed (152). 
Virulence Mechanisms 
Extensive studies have shown that P. aeruginosa is armed with a large arsenal of virulence 
factors, which enabling it to colonize host tissue, avoid the innate immune system, intoxicate and 
damage host cells, and modulate adaptive immune mechanisms. 
Secreted Proteins and Toxic Molecules 
P. aeruginosa is able to secrete a variety of toxins, enzymes and reactive molecules that cause 
extensive damage to host tissues, as well as allow the bacteria to escape clearance via immune 
evasion (18).  Exotoxin A is a cytotoxic enzyme, which is able to ADP-ribosylate the eukaryotic 
elongation factor II, thereby inhibiting protein synthesis within the target host cell leading to cell 
death (99).  Expression of Exotoxin A (encoded by toxA) is complex and involves a cascade of 
regulators that results in the maximal production of Exotoxin A in the stationary growth phase.  
Besides being dependent on low iron concentration, the toxA expression is presumed to be regulated 
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by factors such as PvdS (pyoverdine sigma factor) and connected to cell density and growth phase by 
the las encoded quorum sensing system and vfr (71, 132, 168, 244).   
The P. aeruginosa elastase, LasB, (also called pseudolysin) degrades matrix proteins 
including elastin, laminin, fibrin, and collagen types III and IV (16, 88, 205).  Consequently, LasB 
has the capacity to cause extensive tissue damage.  Elastase is also a potent anti-inflammatory factor 
in mouse models (258).  Besides the destruction of structural proteins, elastase has the capacity to 
inactivate crucial immune system components such as immunoglobulin, serum complement factors 
and the α1-proteinase inhibitor (87, 97, 156).  Together with alkaline protease (described below), 
elastase inactivates the human cytokines interferon γ (INF-γ) and tumor necrosis factor α (TNF-α) 
(176). 
Another protease, LasA, enhances the elastolytic activity of other elastases, including human 
leukocyte elastase and LasB, in a dose-dependent manner (184, 185).  LasA, also known as 
staphylolysin, can lyse S. aureus cells by cleaving the peptidoglycan pentaglycine interpeptides (107).  
LasA enhances the shedding of syndecan-1 from the surface of epithelial cells (175).  Shedding of 
cell surface molecules as soluble extracellular domains is one of the host responses activated during 
tissue injury, and it seems that P. aeruginosa exploits this mechanism to promote its establishment 
within the host (174).  Together with LasB, LasA was one of the first factors of P. aeruginosa found 
to be controlled by quorum sensing (70, 123, 233). 
The endoprotease PrpL has elastolytic activity (248).  Besides cleaving elastin, PrpL is able 
to degrade casein and proteins of the transferrin family, including lactoferrin and decorin.  PrpL 
contributes to P. aeruginosa´s ability to persist in a rat chronic pulmonary infection model (248).  
PrpL production is controlled by quorum sensing like most other secreted virulence factors of P. 
aeruginosa (7, 163). 
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Alkaline protease (AprA) is a metalloprotease and a member of the serralysin family.  AprA 
has maximal enzymatic activity at alkaline pH, hence the name (170).  AprA activity is controlled by 
AprI, a small protease inhibitor (AprI) (55).  The inhibitory protein consists of 131 residues, including 
a signal peptide of 25 residues that is cleaved off during secretion into the periplasm.  The inhibitor is 
entirely located in the periplasm of P. aeruginosa, where its presumed physiological function is to 
protect the periplasmic proteins against the secreted protease (55, 89).  AprA, together with LasB, 
inhibits the activity of Natural Killer cells and reduces lymphocyte proliferation, probably via 
cleavage of IL-2 (181, 232).  The two proinflammatory cytokines, IL-6 and IL-8 are degraded by the 
two proteases AprA and LasB (145). 
The release of hydrogen peroxide and other reactive oxygen species (ROS) by phagocytes 
represents an important defense against bacterial infection.  However, many bacterial pathogens, 
including P. aeruginosa, exploit superoxide dismutase and catalytic enzyme systems to survive the 
oxidative stress within the host.  P. aeruginosa produces at least four catalases; KatA, KatB, KatE 
and KatN and two superoxide dismutases SodB and SodM (also known as SodA) (224).  KatA and, to 
a lesser extent, KatB, but not KatE, have been shown to be required for resistance to peroxide and 
osmotic stresses in P. aeruginosa strain PA14 (127).  Both superoxide dismutase and catalase have 
been found to be required for full virulence of P. aeruginosa in different in vivo models (100, 127).   
A characteristic of P. aeruginosa compared to other fluorescent pseudomonads is the 
production of substantial quantities of the phenazine-derivative pyocyanin.  The production of 
pyocyanin is controlled by quorum sensing, iron and phosphate availability (103).  Pyocyanin 
displays redox activity and induces oxidative stress in cellular systems and thus has the potential to 
impair tissue repair (26).  Pyocyanin has been isolated from sputum of infected patients at levels 
above 100 µM and is reported to modify several host cell responses including altering the platelet 
eicosanoid metabolism and inhibit prostacyclin release (106, 115, 157, 249).  When pyocyanin is 
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reduced by the reaction with NAD(P)H, the reduced pigment immediately reacts with molecular 
oxygen and thereby produces superoxide and by dismutation, hydrogen peroxide (48).  The ability of 
P. aeruginosa to generate phenazines is critical for pathogenicity in both a worm model 
(Caenorhabditis elegans) and a murine model of septicemia (136). 
P. aeruginosa isolated from burn wounds produces high levels of hydrogen cyanide, 
suggesting that cyanide might play a role in P. aeruginosa septicemia in burn patients (130).  This has 
been supported by the finding that cyanide is the mediating factor in the paralytic killing model of C. 
elegans by P. aeruginosa (69).  The toxicity of the cyanide ion is caused by its ability to bind to 
cytochrome c oxidase, thereby inhibiting the enzyme and disrupting the electron transport chain.  In 
P. aeruginosa hydrogen cyanide biosynthesis is catalyzed by the membrane-bound enzyme HCN 
synthase, which forms hydrogen cyanide and CO2 from glycine (30).  Besides being controlled by 
quorum sensing the synthesis of hydrogen cyanide seems to be partly regulated by oxygen availability 
via the anaerobic regulator ANR (183). 
P. aeruginosa produces different lectins that contribute to virulence.  The galactophilic lectin 
PA-IL was the first to be characterized.  It is a broad-spectrum hemagglutinin and agglutinates all 
types of erythrocytes from humans and various animals, as well as thrombocytes and leukocytes.  
Lectins are presumed to participate in the initial infection process where they facilitate binding to the 
respiratory, gastrointestinal or other epithelial surfaces (75, 193).  It has been demonstrated that 
quorum sensing controls expression of lectins (251). 
Type II secretion 
P. aeruginosa possesses a number of dedicated secretion mechanisms for delivering toxins 
and enzymes to the extracellular environment. One such system, the type II secretion system (T2SS), 
is conserved and found among a wide variety of bacterial species (62).  Secretion via the T2SS is a 
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two-step process.  First, initial inner membrane translocation of the secreted protein is achieved in a 
Sec-dependent manner.  Once in the periplasm, the mature polypeptide is then a substrate for the type 
II secretion machinery, which is able to discriminate between exoproteins or periplasmic/outer 
membrane proteins (62).   
P. aeruginosa contains two independent T2SSs: Xcp and Hxc.  Both systems are comprised 
of 11 proteins each (XcpP to XcpZ, HxcP to HxcZ). The XcpT, XcpU, XcpV, and XcpW proteins 
(and presumably their Hxc counterparts) are synthesized as precursor proteins with a short, positively 
charged leader peptide followed by a hydrophobic domain, a conserved feature that is shared with 
pilin (PilA) the major structural subunit of the Type IV pilus (225). Thus, these proteins are referred 
to as pilin-like proteins.  Proteolytic processing of the pilin-like proteins to their mature and 
functional form requires the presence of a prepilin peptidase PilD (XcpA) (9, 62, 165).  Xcp pilin-like 
proteins are mainly localized in the cell envelope of P. aeruginosa, though this localization was found 
to change under physiological conditions (11, 166).  XcpR is a putative ATP-binding protein that is 
required for Xcp-mediated secretion (200, 237).  XcpQ localizes to the outer membrane where it 
forms a ring-shaped structure consisting of 12 to 15 subunits with a central opening through which 
exoproteins may be secreted to the extracellular environment (19, 80).  As with many of the secreted 
proteins described above, expression of the xcp genes is under the positive control of quorum sensing 
(32, 242).  The Xcp system is required for secretion of the majority of the proteins describe above, 
including exotoxin A, elastase (LasB), LasA, PrpL and alkaline protease (AprA). In contrast, Hxc is 
functional only under phosphate limitation, and was described to secrete one enzyme, phosphatase 
LapA (9, 62).     
type III secretion  
In addition to extracellular proteins and type II-mediated secretion, P. aeruginosa uses a type 
III secretion system (T3SS) to promote severe illness via secretion of effector molecules directly into 
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the cytoplasm of target cells.  type III secretion plays a role both in antiphagocytosis and in 
dissemination through effector-mediated damage to host cells (117). Four effector molecules have 
been described in P. aeruginosa: ExoS, ExoT, ExoU, and ExoY.  ExoU is a cytotoxin with 
phospholipase A2 activity (186, 204).  ExoS and ExoT are bifunctional enzymes that encode both 
GTPase-activating properties and ADP-ribosyltransferase activity (76, 111).  ExoY is a cytotoxin 
with adenylate cyclase activity (259).  The importance of these effector molecules, as well as their 
roles in virulence, has been established using mutants with specific disruptions in genes encoding 
portions of the type III secretion apparatus (219).    
Deletion of exoU significantly reduces virulence and development of pathology in the lung 
(63, 84).  ExoS has an intermediate effect on pathogenesis in a mouse model of acute pneumonia due 
to its ADP-ribosyltransferase activity (209).  ExoS and ExoT inhibit phagocytosis by disrupting 
signal transduction cascades, focal adhesins, and preventing cytoskeletal rearrangement (12).  
Expression of the T3SS genes is induced upon intimate contact of P. aeruginosa with host cells in 
vivo and low extracellular calcium concentrations in vitro (66, 238).  Attachment of P. aeruginosa to 
host cells via type IV pili is a prerequisite for contact-dependent activation of the T3SS (227).  
 Alginate 
One distinctive feature of P. aeruginosa pathogenicity is the existence of the mucoid 
phenotype, a condition where bacterial cells overproduce the extracellular polysaccharide alginate 
during chronic colonization of the CF airways.  Presumably, alginate can be expressed at low levels 
under currently unidentified conditions, yet hyper-production of alginate and the resulting mucoid 
phenotype is only known to occur in the CF lung. The mucoid phenotype results from mutation in the 
mucA gene (22), which is located within a gene cluster (algU mucABCD) that appears to encode 
regulators of alginate production in P. aeruginosa (78). These regulators form a signal detection 
system that senses stressful conditions in the surrounding environment, including situations of 
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anaerobic and oxidative stress (78, 154).  The mucA gene codes an anti-sigma factor of AlgU, while 
AlgU is an alternative sigma factor that directs the transcription of alginate biosynthetic genes at the 
algD promoter (142, 143, 207).  Mutations in mucA are specifically enriched within the CF lung and 
lead to a cascade of events resulting in overproduction of alginate and a mucoid phenotype (22).    
It has been suggested that alginate may enhance P. aeruginosa virulence or survival in 
several ways (78).  First, alginate serves as a barrier for bacterial cells against phagocytes and 
antibodies.  Alginate was found to interfere with both opsonic phagocytosis and nonopsonic 
phagocytosis (116, 153, 211).  It is also believed that alginate is capable of quenching oxidative 
radicals released by phagocytic cells (125).  Second, alginate may function as an immunomodulatory 
molecule.  It has been reported that alginate, when used at low doses (close to physiological 
concentration), can stimulate the oxidative burst of neutrophils, while at high concentrations it has an 
inhibitory effect (108, 125).  Alginate also suppresses lymphocyte functions and can act as a mitogen 
together with LPS, which may contribute to hypergammaglobulinemia associated with CF 
exacerbation (41, 139).  Finally, alginate may play an important role in biofilm formation associated 
with chronic CF lung infection (256). 
Biofilms  
An important factor contributing to P. aeruginosa pathogenesis in clinical settings is the 
biofilm mode of growth involved in chronic as well as in acute infections (206).  The Centers for 
Disease Control and Prevention (CDC) and National Institute of Health (NIH) estimate that 65-80 % 
of all human bacterial infections involve biofilms.  Biofilms are defined as sessile microbial 
communities, characterized by cells that are irreversibly attached to a substratum or interface or to 
each other, and embedded in a matrix of self-produced extracellular polymeric substances (EPS).  
Biofilms exhibit an altered phenotype with respect to growth rate and gene transcription (52).  The 
biofilm consists of heterogeneously distributed bacterial cells (cells constitute 5-20 % of the biofilm 
17 
 
volume) embedded in an EPS matrix.  The exact composition of the matrix depends on the phenotype 
of the bacteria producing the EPS.  Mucoid P. aeruginosa strains overproduce the exopolysaccharide 
alginate (composed of uronic acid β-D-mannuronate and its C-5 epimer α-L-guluronate), whereas in 
the non-mucoid matrix the predominant exopolysaccharides are polymers of glucose and rhamnose 
(256).  Also extracellular products such as proteins, nucleic acids, metabolites and absorbed nutrients 
are parts of the biofilm matrix (96, 247).   
 Biofilm development (Figure 1.1) begins from individual planktonic cells, which initiate 
interactions with a surface (biotic or abiotic) in response to cues such as bacterial cell density, nutrient 
availability, and energy sources present in the environment (172, 192).  Functional flagella are 
important for this initial stage of development, as a mutation in flgK has been shown to prevent 
attachment of planktonic cells to an abiotic surface (171).  Once attached to the surface, P. 
aeruginosa cells begin to attach to each other and form small microcolonies, a process that requires 
functional type IV pili (171).  The development of microcolonies gives the biofilm a three-
dimensional structure with distinct architectural and physical/chemical properties (38).  Further, 
biofilm-grown cells differ from planktonic cells in increased expression of exopolysaccharides (44, 
45) and in increased resistance to antibiotics (98).  In contrast to surface-attached biofilms, P. 
aeruginosa forms “raft-like” biofilms in dehydrated CF mucus (255).  It has been established that P. 
aeruginosa biofilms in CF are anaerobic given the low oxygen tension of the mucus environment (4, 
255, 262).  Once the structured biofilm is formed, bacterial cells can be actively dispersed back into 
the environment through a process known as “seeding dispersal” (195).  This dispersal mechanism is 
characterized by “hollowing” of the mature biofilm, which is caused by highly motile cells departing 
the interior of the structure and cell death in a subpopulation of the interior cells (195).  Significantly, 
P. aeruginosa released by seeding dispersal exhibit phenotype and functional diversification, with 
some variants showing an increased ability to disseminate while others manifest accelerated biofilm 
development (110, 243).  
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 Common components of P. aeruginosa biofilms are the polysaccharides, of which there are 
three sub-types: Pel, Psl, and Alginate.  Pel was originally identified from a PA14 transposon library 
as being necessary for maintenance of biofilm structure (67).  While mutation of the pel genes did not 
affect biofilm initiation, colony morphology and the ability of the mutants to bind Congo Red was 
affected (67).  Further analysis demonstrated the requirement for the pel genes for biofilm initiation 
and structure in a pilus-deficient strain, indicating Pel might play a similar role to type IV pili in the 
development of small microcolonies (240).  The Pel polysaccharide is biochemically and genetically 
distinct from Psl.  Psl is a second biofilm-associated polysaccharide that is essential for biofilm 
formation in strains PAO1 and ZK2870 (102, 67, 134, 146).  Inactivation of the psl cluster of genes 
leads to a significant defect in cell-to-surface and cell-to-cell interactions.  Additionally, Psl is 
required for adherence to mucin-coated surfaces and airway epithelial cells, both of which may be 
relevant in the CF lung (134).  After attachment, Psl was shown to be required for the maintenance of 
biofilm structure, indicating this polysaccharide might play a role in holding biofilms together (134).  
While both Psl and Pel are required for biofilm development, there is no data as to their contribution 
to virulence.  As mentioned above, alginate plays a distinct role in the virulence of P. aeruginosa in 
the CF lung.  In fact, there is a distinct correlation between the appearance of alginate overproducing 
P. aeruginosa and a worsening clinical prognosis for CF patients (78).  However, studies have shown 
that alginate is not required for biofilm development in vitro (162, 221, 256).  Alginate-producing and 
-deficient P. aeruginosa strains form morphologically similar biofilms with differing antibiotic 
resistance characteristics.  
P. aeruginosa cells growing as biofilms tolerate 100-1000 times more antibiotics than their 
planktonic counterparts (6, 31, 98).  However, most of the studies reporting elevated resistance of 
biofilm cells describe an increased tolerance to killing rather than growth inhibition (220).  The 
mechanisms for the increased tolerance of biofilm cells towards antibiotics are not fully elucidated.  
Several factors may contribute to the protection of cells in the biofilm mode of growth, perhaps also 
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depending on the properties of various antibiotics.  The matrix is assumed to reduce the diffusion of 
some antibiotics in a rate depending on the nature of the applied compounds and the biofilm matrix 
composition (135).  Decreased diffusion combined with a rapid (enzymatic) degradation of the 
antimicrobial compound could inhibit the penetration of active antibiotics (5).  Finally, the 
accumulation of waste products or the depletion of oxygen and/or nutrients within the biofilm may 
cause the bacteria to enter a non-growing state, and thereby protect them against killing by antibiotics 
that require active growth to be effective (236).  When the antibiotic treatment is ended, surviving 
cells can proliferating and restore the biofilm population.  This is reasonable given that the switch to a 
biofilm mode of growth is considered to be a survival strategy for the bacterium (96).   
Quorum sensing 
In order to be able to survive under changing conditions and in hostile environments, bacteria 
have evolved systems to monitor and respond appropriately to environmental stimuli such as nutrients 
availability, stress and, for some bacteria, cell density.  The latter depends on small diffusible 
signaling molecules constitutively produced by the bacteria, which interact with transcriptional 
activators to couple gene expression with cell population density.  This enables the bacteria to 
function as a group and to some degree exhibit multicellular behavior.  This form of cell to cell 
communication is termed quorum sensing.  In Gram-negative bacteria this phenomenon is mainly 
mediated by -acyl L-homoserine lactones (AHLs), consisting of a conserved homoserine lactone 
ring with an -acyl side chain. AHL structures vary based on the presence or absence of a keto- or 
hydroxy- group on the C3 of the acyl chain and the length and saturation of this chain. 
Two AHL-mediated quorum sensing circuits have been identified in P. aeruginosa: the LasR-
LasI and the RhlR-RhlI system.  The final step in the synthesis of OdDHL (-3-oxododecanoyl-L-
homoserine lactone) and BHL (-butanoyl-L-homoserine lactone) are mediated by LasI and RhlI, 
respectively.  Each system modulates a regulon comprising an overlapping set of genes.  However, it 
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is presumed that a regulatory hierarchy exists in which LasR-OdDHL activates the transcription of 
rhlR (122).  Hence, genes controlled by the RhlI-RhlR system require a functional LasI-LasR system 
for full activation.  Under phosphate-limiting conditions various transcriptional activators, including 
the global regulatory gene Vfr, the alternative sigma factor (σ54) and RhlR itself participate in the 
regulation of rhlR expression (150).  In a heterologous genetic background (E. coli), OdDHL is able 
to compete with BHL for the binding site of RhlR, and thus inhibit the translation of RhlR activated 
genes, indicating that LasI, through OdDHL, controls RhlR activity at a posttranslational level (182).  
In addition, RhlR forms homodimers both in the presence and absence of BHL, whereas OdDHL 
induce monomerization of the RhlR homodimer (241).  LasR forms multimers only in the presence of 
OdDHL and this form is presumed to be the one responsible for its ability to function as a 
transcriptional activator (21, 109). 
Both LasRI and RhlRI function in concert to control the expression of an array of genes, 
many of which encode known virulence factors (71, 123, 177).  LasRI regulates the production of 
elastase, alkaline protease, and toxin A, while RhlRI regulates the production of rhamnolipid, 
pyocyanin, cyanide, lipase, alkaline protease, and elastase (26, 71, 123, 169, 179, 180).  A third 
LasR/RhlR homolog in P. aeruginosa, QscR, induces hypervirulence when mutated (35).  Activation 
of virulence factors by the quorum sensing systems is crucial for successful virulence of P. 
aeruginosa in a mouse model of acute pneumonia (128, 178).  Further, the quorum sensing molecules 
themselves have the ability to modulate the immune system.  P. aeruginosa AHL can induce COX-2 
production through activation of NF-κB, leading to the induction of mucus secretion, vasodilation, 
and edema (218).  AHL molecules can also induce apoptosis of neutrophils and macrophages (230), 
and can increase the production of inflammatory cytokines from airway cells and macrophages (215, 
217, 231). 
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In addition to acute infections, quorum sensing also plays a role in the successful 
establishment of chronic infections in the CF lung.  P. aeruginosa quorum sensing is active in the CF 
lungs, as both quorum sensing systems are up regulated in CF samples (223) and AHLs are detected 
in both sputum samples and lung extracts from CF patients (58, 73).  Quorum sensing affects both the 
development of P. aeruginosa biofilms and the tolerance of these biofilms to antibiotics (46, 90).  In 
fact, the ratio of AHLs detected in the CF lung has been used to support the hypothesis that P. 
aeruginosa is present in the lungs in a biofilm (213).  Disruption of quorum sensing, specifically 
mutations in lasI or rhlI, result in P. aeruginosa that are less virulent than wild type in an animal 
model of chronic lung infection (93, 257).  Combined with the data that suggests AHL receptors 
(lasR/rhlR) are necessary for successful colonization of the lung (20), these results seem to indicate 
that a functional QS system is critical for the establishment of chronic infection by P. aeruginosa 
(34).  This would seem to be an inaccurate claim given the frequency of QS mutants obtained from 
the CF lung (3% to 50%) (91), or the evidence that whole-genome sequencing of early- and late-stage 
isolates of P. aeruginosa from a CF patient showed that lasR was inactivated in the late-stage 
infection isolates (216).  However, these results can be accounted for by data demonstrating a 
mutation in lasR from P. aeruginosa after over 100 generations can give the bacterium a growth 
advantage over other cells in the same culture (201).  Additionally, these mutants are able to use the 
quorum sensing molecules produced by other cells in population to continue QS gene expression 
(201).  
Flagellum  
Another group of virulence factors are attachment and motility organelles, including flagella 
(swimming) and Type IV pili (twitching).  These factors give the bacterium the ability to attach to 
host cells and maneuver around the host environment, facilitating colonization and immune avoidance 
(8, 78, 140, 147).  P. aeruginosa usually possesses a single polar flagellum, responsible for the 
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primary function of bacterial motility (swimming).  A non-flagellated mutant was defective in various 
infection and invasion studies (53, 65, 155).  Interestingly, the flagellar cap protein FliD is involved 
in the adherence of P. aeruginosa to the human respiratory mucin, which is important for the initial 
colonization of the CF airways (8). 
Beyond movement and adherence, the major component of the flagellum, flagellin, is a 
known Pathogen Associated Pattern Recognition Molecule (PAMP) which can promote inflammation 
during P. aeruginosa infection by signaling through TLR5 (10, 86).  In fact, the absence of motility 
does not affect the LD50 of a mouse model of acute pneumonia, while production of excess amounts 
of flagellin lowers the LD50.  Given this role as a potent stimulator of the immune system, it is not 
surprising that flagellin expression is lost during chronic infection (59, 137, 253). 
Type IV pili 
Type IV pili (TFP) also are polarly localized motility and adherence organelles in P. 
aeruginosa.  TFP are responsible for a specialized form of movement known as twitching motility, 
specific adherence to eukaryotic host cells, and nonspecific binding to other surfaces where these pili 
could mediate intimate contact and bacterial colonization (147).  The pilA gene codes for the major 
structural subunit of TFP in P. aeruginosa, and is essential for Type IV pilus expression and function 
(245).  Pilin (PilA) is transcribed as a pre-protein and contains an amino-terminal short leader 
sequence that is cleaved prior to assembly of the mature protein into the pilus fiber.  Cleavage of the 
leader sequence is carried out by the prepilin peptidase PilD (226).  PilD is also required for 
processing the structurally related Xcp pilin-like proteins involved in type II secretion (described 
above). The resulting mature pilin protein contains an extended, highly conserved, and hydrophobic 
N-terminal α-helical region followed by a globular C-terminal domain terminating in a disulphide-
bonded loop (DSL) (40, 173). The DSL varies in size between different pilin alleles (120).  The 
mature pilin subunits are predicted to assemble such that the N-terminal α-helical regions form the 
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core of the pilus structure, with the globular C-terminal domains on the outside and exposed to the 
environment (28). Assembly of pilin subunits occurs on the periplasmic face of the inner membrane 
and is an energy dependent process that requires the ATPase PilB.  As the pilus fiber grows it passes 
through a pore in the outer membrane. The pore is composed of PilQ, a protein that belongs to the 
super family of secretins, which forms a hexameric ring-like structure (36, 252) (Figure 1.2).  PilB is 
an ATPase that is localized to the poles of the inner membrane of P. aeruginosa, where it is involved 
in the assembly of the pilin monomers into the mature pilus structure (33, 148).  A homolog of PilB, 
PilT is another TFP-associated ATPase in P. aeruginosa that is involved in disassembly and 
subsequent retraction of the pilus fiber (245).  Loss-of-function mutations in pilB result in a non-
piliated phenotype (164).  Conversely, a loss-of-function mutation in pilT results in hyperpiliation, a 
loss in the ability of the bacteria to undergo twitching motility on a solid surface (246), defective type 
III secretion dependent cytotoxicity in vitro, and reduced virulence in vivo (37).  This reduction in 
virulence is likely due to a defect in dissemination, as pilT mutants are able to efficiently infect mouse 
lungs, but are unable to spread to peripheral organs (263). 
TFP are required for P. aeruginosa adherence to host cells and tissue (51). Currently, pilin is 
believed act as both the structural subunit and the adhesin.  The in vitro binding of TFP to asialo-GM1 
and asialo-GM2 implicated the exposed C-terminal disulfide-bonded loop, located within residues 128-
144 of the pilin monomer on the tip of the pilus fiber, as the TFP-associated adhesin (27, 51, 101, 
199).  However, the nature of P. aeruginosa binding to epithelial cells, as well as recent work 
demonstrating the lack of live P. aeruginosa bacteria binding to asialo-GM1/GM2, have raised 
questions as to the role of pilin in TFP-mediated adherence (28).  In response to this new data, we 
have hypothesized that another pilus-associated protein (PilY1) is the pilus-associated adhesin. 
The PilY1 gene was originally identified in a transposon screen (3) as being required for 
twitching motility and surface TFP expression in P. aeruginosa.  pilY1 is located in an operon with 
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six other TFP-associated genes (fimUpilVWXY1Y2E).  The PilY1 protein is approximately 117 kDa 
and localizes to sheared pilus fractions (3); however, little is known about the role PilY1 plays in P. 
aeruginosa TFP biogenesis. Interestingly, the C-terminus of PilY1 shares 27% amino acid identity 
with the C-terminus of PilC2 from eisseria gonorrhoeae. PilC2 has been identified as the TFP-
associated adhesion in . gonorrhoeae due to its ability to bind cells of human origin, and 
competitively block the adherence of piliated gonococci (198). 
TFP assembly requires the presence of both cAMP and the global transcription factor, Vfr 
(13, 105).  Vfr is a homologue of the E. coli catabolite repressor protein CRP (cAMP receptor 
protein), and has been shown to bind to a CRP-binding consensus sequence (CCS) located at the 
promoter region of lasR and to positively regulate expression of exotoxin A and protease production 
(2, 244).  In addition to Vfr, the two-component regulatory system AlgZ/AlgR is required for TFP 
assembly in P. aeruginosa.  Phosphorylation of AlgR results in activation of the fimU-pilVWXY1Y2E 
operon and, consequently, biogenesis of a functional pilus structure (17).  While it has been 
demonstrated that pilin expression is controlled by PilS/PilR (24, 25) and RpoN (234), the effects of 
AlgZ/AlgR and of cAMP/Vfr are specific to the pilY1 operon (17, 105).  This would suggest that 
there are multiple modes of TFP regulation and that, under certain conditions, pilY1 expression can be 
regulated independent of pilin. 
The aim of the work presented in this document was to further characterize the role of PilY1 
in P. aeruginosa TFP biogenesis and function.  How does PilY1 control TFP expression?  Given the 
homology between PilY1 and PilC in . gonorrhoeae, could PilY1 act as the TFP-associated adhesin 
in P. aeruginosa?  Answers to both questions would not only lead to further insight into the 
mechanism of TFP biogenesis, but could also provide a novel target for inhibiting P. aeruginosa 
colonization of epithelial surfaces and subsequent infection. 
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Figure 1.1.  Biofilm development in Pseudomonas aeruginosa. 1) Initial attachment to substratum, 
2) the bacteria adhere to each other 3) forming small microcolonies, 4) the three-dimensional 
structure of the mature biofilm develops, and 5) cells are released (sloughing off) and re-colonize new 
areas of substratum via “seeding dispersal”. (Adapted from graphic by Peg Dirckx and David Davies, 
Center for Biofilm Engineering, Montana State University, Bozeman.) 
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Figure 1.2.  Overview of Pseudomonas aeruginosa Type IV pili.  Pilin subunits (green circles) are 
localized to the inner membrane after cleavage of their leader sequence by PilD (not pictured).  The 
pilin subunits are then assembled into a mature pilus structure through the actions of the ATPase PilB 
(orange).  The assembled fiber extends through the outer membrane via a PilQ pore, and can be 
retracted by the PilT-dependant removal of pilin subunits from the base of the assembled fiber.  PilY1 
(pink) associates with the mature pilus fiber, but it is unclear how it is localized to this structure from 
the cytoplasm. 
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Pseudomonas aeruginosa is an environmental bacterium capable of causing a wide variety of 
infections. In addition, P. aeruginosa is a leading cause of hospital-acquired pneumonia and the 
primary pathogen associated with chronic respiratory infection in individuals with cystic fibrosis. P. 
aeruginosa pathogenesis involves bacterial attachment to host cells and tissue. Adherence is mediated 
by Type IV pili (TFP), which are polymeric surface fibers composed primarily of pilin subunits. In 
addition to their role in adherence, TFP facilitate twitching motility by undergoing rounds of 
extension and retraction. An exposed epitope on the terminal pilin subunit of TFP is believed to 
mediate P. aeruginosa binding to host glycosphingolipids. However, recent work has shed doubt on 
the direct involvement of pilin and the importance of glycolipids in P. aeruginosa adherence. We 
hypothesized that PilY1, a putative pilus-associated protein, may play a direct role in TFP-dependent 
bacterial adherence. To test this hypothesis, we constructed a non-polar pilY1 deletion mutant and 
assessed pilus-associated phenotypes. We confirmed a previous report that pilY1 is required for pilus 
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biogenesis and demonstrated that surface fiber production can be restored in the pilY1 mutant by 
disruption of the pilus retraction gene pilT. Restoration of TFP in the non-retractile double mutant 
(pilY1, pilT) indicates that PilY1 is conditionally required for TFP biogenesis. We further 
demonstrated that association of PilY1 with surface TFP fibers involves a set of pilin-like proteins. 
To assess the role of PilY1 in P. aeruginosa adherence, we developed a biologically relevant 
infection model using primary well-differentiated human airway epithelial cell cultures. In this 
system, wild type and non-retractile (pilT) strains showed robust adherence. In contrast, non-piliated 
strains and piliated non-retractile mutants lacking PilY1 were non-adherent. Overall, our results 
indicate that adherence of P. aeruginosa to primary well-differentiated host cell requires both TFP 
and PilY1 and that PilY1 is a bi-functional protein with distinct roles in TFP biogenesis and 
adherence. 
Introduction 
Pseudomonas aeruginosa, an environmental bacterium, is a major source of fatal nosocomial 
infections and the primary cause of morbidity and mortality in patients with cystic fibrosis (CF) (20, 
25).  The ability of P. aeruginosa to cause infection requires the expression of a variety of virulence 
factors including Type IV pili (TFP) (49).  TFP are filamentous surface appendages expressed by a 
wide variety of gram-negative human, animal and plant pathogens including eisseria gonorrhoeae, 
eisseria meningitidis, Vibrio vulnificus, enterohemorrhagic Escherichia coli, Francisella tularensis, 
non-typeable Haemophilus influenzae, Burkholderia pseudomallei, Dichelobacter nodosus and 
Kingella kingae. TFP play a crucial role in host colonization and promote numerous phenotypes 
including surface attachment, DNA uptake, auto-aggregation, biofilm formation and motility.  In P. 
aeruginosa, TFP are required for adherence to host tissue, colonization, virulence and for the 
formation of robust biofilms (10, 14, 34, 42, 59).  In addition, P. aeruginosa TFP mediate a form of 
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surface movement known as twitching motility through extension and retraction of pilus fibers (38, 
54).   
The assembly and function of TFP in P. aeruginosa involves more than 40 gene products 
(37).  TFP are polymers composed primarily of a single repeating subunit termed pilin, which is 
encoded by the pilA gene in P. aeruginosa (56).  Pilin is synthesized as a pre-protein with a short 
leader sequence that is removed by the integral inner membrane protease PilD prior to assembly of 
the mature protein into the pilus fiber (57).  The mature form of pilin contains an extended, 
hydrophobic N-terminal α-helical region followed by a globular C-terminal domain terminating in a 
disulfide-bonded loop (15, 27, 43).  Pilin subunits are predicted to assemble such that the N-terminal 
α-helical regions form the core of the pilus structure, and the globular C-terminal domains are 
exposed on the exterior surface of the fiber (15).  The pilus is assembled on the periplasmic surface of 
the inner membrane and extruded across the outer membrane via a pore complex composed of the 
secretin protein, PilQ (5, 12, 65).  Although pilin is the major structural component of the pilus, other 
proteins are associated with the fiber and may play structural or functional roles. In . gonorrhoeae, 
six proteins (PilH, PilI, PilJ, PilK, PilL, and PilV) are known to be associated with the TFP fraction 
(62). These proteins, have homology to the highly conserved N-terminus of pilin and are thus termed 
“pilin-like” proteins (62).  In . meningitidis, PilX, a homolog of . gonorrhoeae PilL, was shown to 
integrate into pilus fibers as a minor subunit (28).  A homologous set of pilin-like proteins (FimU, 
PilV, PilW, PilX, and PilE) is required for TFP biogenesis in P. aeruginosa (1, 2, 3, 48); however, 
their association with the pilus fiber and specific function remains to be determined.  
 Type IV pili are dynamic structures that undergo cycles of extension and retraction (54), a 
process that involves two cytoplasmic membrane associated ATPases, PilB and PilT. PilB is required 
for the assembly of pilin monomers into a mature fiber (11, 41, 60), while PilT is involved in 
disassembly of pilin monomers and subsequent retraction of TFP (11, 61).  Loss-of-function mutation 
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of pilT results in hyperpiliation and loss of twitching motility due to the inability of formed pilus 
fibers to retract (61).  Additionally, inactivation of pilT results in complete loss of cytotoxicity in 
vitro, presumably due to the inability of the TFP to retract and allow for more intimate contact 
between the bacteria and host cell (13).  However, pilT mutants are only slightly reduced for 
virulence in vivo (13).  This reduction in virulence is likely due to the defect in twitching motility, as 
pilT mutants are able to efficiently infect mouse lungs, but are unable to spread to peripheral organs 
(69).     
In addition to their function in twitching motility, TFP also mediate adherence of P. 
aeruginosa to eukaryotic cells (10, 19, 26, 50).  While the molecular basis for this interaction has 
been the subject of many studies, the actual mechanism for TFP-mediated P. aeruginosa adhesion 
remains controversial. Previous studies suggest that the major structural subunit (pilin) of TFP may 
be directly involved in adherence of P. aeruginosa to host cells. Specifically, purified P. aeruginosa 
pili were shown to bind to the GalNAcβ1-4Gal moiety of the non-sialylated glycosphingolipids 
asialo-GM1 and asialo-GM2, which are abundant on the apical surface of mammalian epithelial cells 
(36, 53). Fab fragments, generated from monoclonal antibodies, specific for the exposed C-terminal 
disulfide-bonded loop (DSL) region of pilin, inhibited adhesion of purified P. aeruginosa TFP to 
human buccal epithelial cells (18).  Subsequent studies demonstrated that adherence of purified TFP 
to asialo-GM1 can be inhibited by a synthetic peptide corresponding to the C-terminal DSL of pilin 
and by the disaccharide GalNAcβ1-4Gal (52, 53, 67).  Further experimentation showed that the 
adhesive moiety of TFP, responsible for asialylated glycosphingolipid binding, is only exposed at the 
distal tip of purified TFP fibers (36). Based on these studies, it is widely reported that the exposed C-
terminal DSL of pilin serves as the P. aeruginosa TFP-associated adhesin (7, 51).     
More recent experiment results have raised questions as to the role of pilin in TFP-mediated 
adherence as well the identity of the pilus receptor.  Specifically, Emam et al. showed that intact 
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piliated P. aeruginosa are unable to bind to either asialo-GM1 or asialo-GM2 in contrast to purified pili 
from the same strains (21).  Second, it has been established that P. aeruginosa preferentially binds 
basolateral surfaces of epithelial cell monolayers, or damaged areas of the monolayer where 
basolateral surfaces are exposed (22, 35).  Given that asialo-GM1 is predominantly presented on the 
apical surface of airway epithelial cells (55), pilin may not be the only TFP-associated protein 
involved in adherence of P. aeruginosa to host epithelial cells.  
Although the molecular interactions involved in P. aeruginosa adherence remain to be more 
clearly defined, the mechanism of TFP-mediated adhesion has been characterized in other gram-
negative bacteria. In . gonorrhoeae, a minor TFP-associated protein PilC has been identified as the 
adhesin due to its ability to bind cells and competitively block the adherence of piliated gonococci 
(46).  Additionally, PilC is required for TFP biogenesis in both . gonorrhoeae and . meningitidis 
(31, 39, 46, 47).  Association of PilC with the gonococcal TFP fraction requires expression of the 
pilin-like proteins PilH, PilI, PilJ, PilK, PilL, and PilV (62). PilC was initially reported to be essential 
for TFP biogenesis, but work by Wolfgang et al. demonstrated that deletion of the pilus retraction 
gene pilT could suppress the TFP biogenesis defect of a pilC mutant (64).  Additionally, the pilin-like 
proteins in both . gonorrhoeae and . meningitidis are required for TFP biogenesis, but this 
requirement can also be suppressed by a corresponding deletion of pilT (9, 62).  Therefore, neither 
PilC, nor the pilin-like proteins, are essential for TFP biogenesis but are believed to play a role in 
stabilizing the TFP structure against retraction by PilT (39, 65).  
P. aeruginosa expresses a TFP-associated protein named PilY1 that has homology to . 
gonorrhoeae PilC, but this protein has not been fully characterized with respect to its role in TFP 
biogenesis and TFP-mediated adherence (1).  The pilY1 gene was originally identified in a transposon 
mutant screen for genes that affect TFP biogenesis (1). Interestingly, pilY1 is located in an operon 
(fimUpilVWXY1Y2E) with five genes that encode pilin-like proteins (described above).  PilY1 is 
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approximately 117-kD in size and has 27% amino acid identity to . gonorrhoeae PilC within a 257-
amino acid region in the C-terminus.  A P. aeruginosa mutant carrying a polar insertion in pilY1 
failed to produce TFP fibers but accumulated intracellular processed pilin subunits, suggesting pilY1 
is required for fiber assembly.  Full restoration of TFP biogenesis in this mutant required 
complementation with pilY1 and additional downstream genes (1).  Finally, the PilY1 protein was 
shown to localize to TFP fractions recovered from the surface of P. aeruginosa  (1).  Given the 
homology between PilY1 and PilC, as well as the apparent similarities between the TFP systems of P. 
aeruginosa and . gonorrhoeae, we hypothesize PilY1 plays a role in adherence of P. aeruginosa to 
host epithelial cells.  Here, we demonstrate that PilY1 is conditionally required for TFP expression, 
such that TFP biogenesis is pilY1-dependent but the defect can be suppressed by inactivation of pilT.  
Additionally, we demonstrate the requirement for PilY1 in TFP-associated adherence of P. 
aeruginosa to well-differentiated human airway epithelial cell cultures following injury. 
Results 
PilY1 is required for TFP biogenesis. It was previously reported that polar transposon insertions in 
P. aeruginosa pilY1 result in a defect in TFP production (1).  To determine the role of PilY1 in TFP 
biogenesis, we constructed a non-polar pilY1 deletion in wild type piliated P. aeruginosa strain PAK. 
The ability of the wild type parent and pilY1 mutant to produce TFP was determined by transmission 
electron microscopy (TEM). Thin polar fibers, extending from the surface of the wild type strain, 
were readily detected (Fig. 2.1). In contrast, we were unable to detect similar fibers on the surface of 
the pilY1 mutant, which was indistinguishable from a non-piliated pilA mutant (32) (Fig. 2.1). To 
confirm the TEM results wild type and mutant strains were grown on glass slides, and surface TFP 
were stained with pilin-specific antibody and examined by immunofluorescence microscopy (IF) 
(Fig. 2.2).  The IF technique allowed us to specifically label TFP, and to visualize a larger population 
of bacteria. The wild type strain produced abundant TFP, while no TFP could be detected in 
association with either the pilY1 or pilA mutant (Fig 2.2). 
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In addition to our qualitative assessment of TFP, we performed semi-quantitative analysis of 
TFP production by comparing the relative amount of pilin in pilus fractions recovered from the 
surface of the wild type and mutant strains (Fig. 2.3A). Since pilin is the major structural subunit of 
TFP, the amount of pilin recovered in pilus fractions correlates with TFP abundance.  While pilin 
could be recovered from the wild type strain, we were unable to detect pilin in the TFP fraction from 
the pilY1 mutant (Fig. 2.3A). Comparison of the pilus preparation from the pilY1 mutant to a serial 
dilution of the pilus preparation from the wild type strain indicated at least a 100-fold reduction in 
TFP produced by the pilY1 mutant (data not shown).  Despite the lack of surface TFP, wild type 
levels of the pilin subunit were detected by Western blot in whole cells lysates from the pilY1 mutant 
(Fig. 2.3C).  These results indicate that that the pilY1 mutant is defective for TFP biogenesis at a step 
prior to extrusion of the fiber across the outer membrane.   
To rule out the possibility that the TFP biogenesis defect in the pilY1 mutant was due to a 
polar effect of the deletion on neighboring genes, we assessed the ability of cloned pilY1 to restore 
TFP production when expressed in trans. The complete pilY1 open reading frame (GeneBank 
#EU234515) was cloned into plasmid pMMBGWV2 (30), such that pilY1 expression was under the 
control of an IPTG-inducible tac promoter.  The complementation plasmid (pPa-pilY1) was 
transferred to the pilY1 mutant and expression conditions were optimized such that wild type levels of 
PilY1 could be detected in whole cell lysates by Western blot using PilY1-specific polyclonal 
antiserum (Fig. 2.3D).  Under these conditions, expression of plasmid-borne pilY1 was sufficient to 
restore TFP production (Fig. 2.1, 2.2, and 2.3A). Over-expression of pilY1 at had no measurable 
effect on TFP abundance, indicating that wild type levels of PilY1 are not limiting for TFP biogenesis 
(data not shown). Overall, these results provide definitive evidence that PilY1 is required for the 
biogenesis of P. aeruginosa TFP. 
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Inactivation of pilT suppresses the TFP biogenesis defect in a pilY1 mutant.  PilT is an ATPase 
required for retraction of TFP in P. aeruginosa, eisseria sp., and other gram-negative bacteria (37).  
Inactivation of pilT results in a non-retractile, non-twitching, and hyperpiliated phenotype in P. 
aeruginosa (61) (Fig. 2.3A, and 2.4). In . gonorrhoeae, inactivation of pilT suppresses the TFP 
biogenesis defect of a mutant lacking PilC, a pilus-associated protein required for TFP biogenesis (31, 
47, 64).  PilC was subsequently shown to be an inhibitor of PilT-driven fiber retraction rather than an 
essential factor in fiber formation (39).  Given these findings, as well as the limited homology 
between P. aeruginosa PilY1 and gonococcal PilC, we examined the effect of inactivation of pilT on 
TFP biogenesis in the absence of pilY1. 
To determine if pilT inactivation could suppress the TFP defect of a pilY1 mutant, we 
introduced the non-polar pilY1 deletion in a pilT mutant background (58). The resulting pilY1, pilT 
double mutant produced detectable TFP (Fig. 2.1, 2.2, and 2.3A) in the absence of pilY1 expression 
(Fig. 2.3D), demonstrating that the TFP biogenesis defect of a pilY1 mutant is suppressible by 
inactivation of pilT. To confirm that the restoration of TFP production in the absence of PilY1 was 
due to pilT inactivation, we complemented the pilY1, pilT mutant with plasmid-expressed pilT (pPa-
pilT).  When wild type expression of PilT was restored (Fig. 2.3E), TFP biogenesis was abolished, 
resulting in a TFP phenotype indistinguishable from a pilY1 mutant (Fig. 2.1, 2.2, 2.3A).  Conversely, 
complementation of the pilY1, pilT mutant with plasmid-borne pilY1 (Fig. 2.3D) resulted in an 
increase the level of TFP similar to that seen in a pilT mutant (Fig. 2.1, 2.2, and 2.3A). Regardless of 
PilY1, TFP are formed in the absence of pilT.  Given that pilT is involved in retraction of assembled 
fibers, our data suggests the TFP defect seen in a pilY1 mutant is not associated with TFP fiber 
assembly.  Instead, analogous to PilC in Neisseria, PilY1 may play a role in stabilizing the pilus 
structure by counteracting the retraction force from PilT.  
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Localization of PilY1 to sheared TFP fractions requires additional genes in the pilY1 operon.  
PilY1 was previously shown to localize to the sheared pilus fraction of a piliated wild type strain (1). 
To confirm this result and to assess the contribution of other TFP-associated proteins to PilY1 
localization, we used PilY1-specific antiserum to probe TFP fractions recovered from the surface of 
the wild type and mutant strains (Fig. 2.3B).  As expected, PilY1 was present in the wild type TFP 
fraction, but not detected in fractions collected from the non-piliated pilY1 mutant or the piliated 
pilY1, pilT double mutant. Complementation of the pilY1 and pilY1, pilT mutants with plasmid-
encoded pilY1 resulted in restoration of PilY1 to the TFP fractions (Fig. 2.3B). The TFP fraction from 
the non-piliated pilA mutant was devoid of PilY1 (Fig. 2.3B), despite the fact that PilY1 could be 
detected in whole cell lysate from the same strain (Fig. 2.3D). The later result demonstrates that 
PilY1 localization to the TFP fraction requires the presence of surface pili. While not definitive, this 
result suggests that PilY1 may specifically localize to the assembled pilus fiber.   
It is currently unclear if localization of PilY1 to the sheared TFP fraction requires additional 
proteins. However, pilY1 is located in an operon with six additional genes (fimU-pilVWXY1Y2E) (1, 
4).  Five of the genes in this operon, encode pilin-like proteins (FimU, PilV, PilW, PilX, and PilE), 
which are required for pilus biogenesis (1, 2, 3, 48) and share homology with pilin-like proteins in 
eisseria that are required for the localization of PilC to the pilus fraction (62). Given the apparent 
similarity between P. aeruginosa PilY1 and gonococcal PilC, we examined the requirement of genes 
in the pilY1 operon for localization of PilY1 to the sheared pilus fraction. To this end, we created an 
unmarked deletion of the entire pilY1 operon. The resulting mutant strain (fimU-pilE) was defective 
for TFP biogenesis (Fig. 2.5A). As was seen with the pilY1 mutant, wild type levels of the pilin 
subunit were detected by Western blot in whole cells lysates from the fimU-pilE mutant (Fig. 2.5C), 
indicating that the defect in TFP biogenesis was not due to reduced subunit availability. 
Complementation of the fimU-pilE mutant with a plasmid-borne copy of the operon (pPa-fimU-pilE) 
was sufficient to restore TFP biogenesis (Fig. 2.5A) and localization of PilY1 to the TFP fraction 
57 
 
(Fig. 2.5B). In contrast, complementation of the fimU-pilE mutant with plasmid-expressed pilY1 
alone (Fig. 2.5D) was not sufficient to restore TFP production (Fig. 2.5A) or localization of PilY1 to 
the sheared surface fraction (Fig. 2.5B). These results are consistent with previous studies showing 
that other genes (fimU, pilV, pilW, pilX and pilE) within the pilY1 operon are required for TFP 
biogenesis and not pilin expression. Further, these results demonstrate that PilY1 cannot be detected 
in sheared surface fractions collected from non-piliated strains, regardless of its presence in whole 
cell lysates. While this result suggests that localization of PilY1 to surface fractions may require 
additional TFP biogenesis components, we cannot rule out the possibility that our fractionation 
technique is insufficient for isolation of surface localized PilY1 in the absence of TFP fibers. 
In the previous section, we demonstrated the ability of a pilT deletion to suppress the TFP 
biogenesis defect of a pilY1 mutant (Fig. 2.3).  To determine whether other genes in the pilY1 operon 
are conditionally required for TFP biogenesis, we introduced the fimU-pilE deletion into the pilT 
mutant background. The resulting strain (fimU-pilE, pilT) produced TFP (Fig. 2.5A), indicating that 
the entire pilY1 operon is conditionally required for TFP biogenesis and not essential for fiber 
assembly. The ability to restore TFP production in the absence of the pilin-like genes (fimU-pilE, 
pilT) provided us with the opportunity to determine their role in PilY1 localization in an otherwise 
piliated background. Complementation of the fimU-pilE, pilT mutant with plasmid-expressed pilY1 
resulted in wild type levels of PilY1 in whole cell lysates (Fig. 2.5D); however, PilY1 was not 
detectable in the sheared TFP fraction (Fig. 2.5B). The results presented in this section indicate that 
localization of PilY1 to sheared, surface TFP fractions requires both the production of TFP fibers and 
pilin-like proteins encoded by the pilY1 operon. 
PilY1 is required for P. aeruginosa interaction with human lung pneumocyte cells.  Previous 
studies have shown that TFP are required for P. aeruginosa adherence to mammalian cells (10, 14, 
18, 19). Host cell adherence is required for in vivo activation of the P. aeruginosa contact-dependent 
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type III secretion system (T3SS), which causes host cell cytotoxicity (13, 14, 58, 66). Although our 
pilY1 mutant lacks measurable TFP in vitro, the defect appears to be at the level of fiber stabilization 
and not TFP assembly. We hypothesized that transient fiber expression in the presence of the 
appropriate host cell receptor may be sufficient to promote host cell interaction.  To assess the role of 
pilY1 in host cell interactions, we measured the ability of the pilY1 mutant to adhere to and cause 
cytotoxicity in cultured human type II pneumocyte-like carcinoma (A549) cells following infection.  
 Consistent with previous reports (10, 13), wild type P. aeruginosa adhered to A549 cells to a 
greater extent than the non-piliated pilA mutant (Fig. 2.6). In addition, the wild type strain was more 
cytotoxic than the pilA mutant and a pscC mutant, as measured by the release of the host cytoplasmic 
enzyme lactate dehydrogenase (LDH) (Fig. 2.6).  The pscC mutant is non-cytotoxic due to a defect in 
the T3SS (66).  The pilY1 mutant showed a significant reduction in both adherence and cytotoxicity 
compared to the wild type strain, and was indistinguishable from the pilA mutant (Fig. 2.6). 
Complementation of the pilY1 mutant with plasmid-encoded pilY1 was sufficient to restore both 
adherence and cytotoxicity to a wild type level.  Thus, the defect in adherence and cytotoxicity is 
specific to the pilY1 deletion.  
Our findings indicate that pilY1 is required for P. aeruginosa to establish pathogenic 
interactions with host cells, but it is not clear whether the requirement is solely at the level of TFP 
production or whether PilY1 directly mediates TFP-dependent adherence.  To distinguish between 
these possibilities, we assessed adherence and cytotoxicity of piliated pilT mutants in the presence or 
absence of pilY1 (pilT versus pilY1, pilT) (Fig. 2.6). Both mutants were defective for adherence and 
cytotoxicity and were indistinguishable from the non-piliated strains (pilA and pilY1).  The inability 
of pilT mutants to adhere despite being piliated suggests that pilus retraction is a prerequisite for 
interaction with A549 cells, and prevented us from drawing any conclusions about the role of PilY1 
in this system.  
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TFP are required for infection and invasion of primary human airway epithelial cell cultures.  
Mutants lacking the pilus retraction protein PilT, were previously reported to display lower levels of 
adherence to non-polarized or transformed epithelial cell lines (13, 58).  The lack of binding to A549 
cells by the piliated pilT and pilY1, pilT mutants (Fig. 2.6) may be due to their inability to undergo 
pilus retraction and twitching motility (Fig. 2.4), a process that is likely to facilitate tight association 
of P. aeruginosa with host cells.  Experiments by Fleiszig et al. and Lee et al. demonstrated 
preferential binding of P. aeruginosa to the basolateral surfaces of well-differentiated mammalian 
epithelial cells (22, 35).  Furthermore, pilT mutants are more virulent in animal infection models than 
non-piliated pilA mutants, suggesting that pilT mutants may retain the capacity to adhere to host cells 
in vivo, despite their apparent defect in vitro (13). Based on these studies, we hypothesized that 
polarized or well-differentiated cell cultures may provide a more robust model for determining the 
role of PilY1 in TFP-mediated adherence.  To more accurately model the host environment, we 
evaluated P. aeruginosa infection of well-differentiated human airway epithelial (HAE) cell cultures 
(23).  HAE cell cultures are derived from primary human lung epithelial cells, which are allowed to 
propagate and differentiate into multi-layered cell culture that mimics the organization and structure 
of the airway epithelium in vivo (Fig. 2.7). 
To determine the feasibility of using the HAE cell culture system as a basis for testing P. 
aeruginosa interactions with host cells, we performed infection experiments with wild type piliated P. 
aeruginosa, the isogenic non-piliated pilA mutant and a non-cytotoxic T3SS mutant (pscC). Wild 
type P. aeruginosa rarely adhered to the ciliated apical cell surface but caused local infection foci 
within 3 hours post-deposition onto the apical surface of HAE cell cultures (Fig. 2.7).  The wild type 
strain appeared to interact efficiently with exposed basolateral surfaces of ciliated cells and the entire 
surface of undifferentiated basal cells (Fig. 2.7). Bacterial adherence appeared to be associated with 
host cell rounding and detachment. By 12 hours, the wild type infection spread intercellularly to 
encompass the entire HAE culture. In contrast, mutants lacking pilA or pscC did not adhere to or 
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interact with the epithelial cultures and could be completely removed from the surface of the 
epithelium by gentle washing 12 hours post-deposition (Fig. 2.7). These results indicate that P. 
aeruginosa can efficiently interact with exposed basolateral surfaces of well-differentiated epithelial 
cells but that TFP and T3SS are required for initial infection and subsequent invasion of HAE cell 
cultures. Our observations are consistent with previous studies showing that P. aeruginosa 
preferentially binds to exposed basolateral surfaces of well-differentiated host cells and injured or 
remodeling epithelial tissues (16, 35, 44, 45). 
PilY1 is required for adherence of P. aeruginosa to injured HAE cell cultures. To assess the role 
of PilY1 in TFP-mediated adherence, we modified the HAE infection system to artificially expose 
underlying basal cells. Specifically, HAE cultures were mechanically abraded to expose the basal 
cells prior to P. aeruginosa infection.  To assess bacterial adherence, infections were carried out using 
strains harboring a plasmid that constitutively expresses GFP (pSMC21) (6).  The injured HAE 
cultures were infected with GFP-expressing strains for 45 minutes, washed, and adherent bacteria 
were visualized by fluorescence microscopy.  Wild type P. aeruginosa adhered to the injured region 
of the HAE culture, but not to the adjacent intact ciliated epithelium (Fig. 2.8).  In contrast, the non-
piliated pilY1 and pilA mutants did not bind to the injured cell cultures (Fig. 2.8) indicting a 
requirement for TFP.  Adherence of the pilY1 mutant could be restored by complementation with 
plasmid-encoded pilY1.  
To directly examine the role of PilY1 in TFP-mediated adherence, we compared binding of 
the piliated, non-retractile pilT mutant to the piliated pilY1, pilT double mutant. The pilT mutant, 
which displayed poor binding to A549 cells (Fig. 2.6), adhered efficiently to the damaged region of 
the HAE culture (Fig. 2.8). Conversely, the piliated pilY1 mutant (pilY1, pilT) mutant showed little or 
no binding to the injured HAE cultures (Fig. 2.8). Complementation of the pilY1, pilT mutant, with 
plasmid-expressed pilY1, restored adherence to the injured HAE cultures (Fig. 2.8).  To confirm the 
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results of our injured HAE binding experiments, we directly visualized bacterial-host cell interactions 
in fixed histological cross-sections of the infected cultures using light microscopy.  In all cases, the 
bacterial strains that adhered to the HAE injury site demonstrated specific association with exposed 
basal cells and basolateral surfaces (Fig. 2.9).  In contrast, the non-adherent mutants were rarely 
detected in association with exposed basal cells present in the injury site (Fig. 2.9). Our results 
indicate that binding of P. aeruginosa to exposed basolateral surfaces of well-differentiated epithelial 
cells is TFP-dependent, and does not require pilus retraction.  Further, the adherence of P. aeruginosa 
to injured HAE cell cultures appears to require PilY1 localization to the surface TFP fraction, 
suggesting that PilY1 may function as a TFP-associated adhesin.  
Materials and Methods 
Bacterial strains and growth conditions  
All mutant P. aeruginosa strains used in this study were derived from the prototypic 
laboratory strain PAK and are referenced in Table 2.1.  The PAKpilY1 and PAKpilY1, pilT strains 
were constructed by introducing a deletion allele for pilY1 (encoded by the pEXGm∆pilY1 plasmid) 
onto the chromosome of PAK and PAKpilT using a previously described method (29).  The 
pEXGm∆pilY1 plasmid was constructed by amplifying and splicing chromosomal fragments flanking 
the pilY1 ORF by SOE PCR as previously described (66) using pilY1 5’/pilY1 SOE 3’ and pilY1 
3’/pilY1 SOE 5’ oligonucleotide pairs (Table 2.2).  The resulting deletion allele carries an in-frame 
stop codon in place of amino acid residues 51 through 801 of the pilY1 coding sequence.  
Oligonucleotide pair pilY1 5’/pilY1 3’ (Table 2.2) were used to confirm pilY1 deletion as previously 
described (29).  The PAKfimU-pilE and PAKfimU-pilE, pilT strains were constructed by introducing 
a deletion allele for the pilY1 operon (fimUpilVWXY1Y2E, encoded by pEXGm∆fimU-pilE) onto the 
chromosome of PAK and PAKpilT using a previously described method (29).  The pEXGm∆fimU-
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pilE plasmid was constructed by amplifying and splicing chromosomal fragments that flank the pilY1 
operon by SOE PCR as previously described (66) using fimU-pilE 5’/fimU-pilE SOE 3’ and fimU-
pilE 3’/fimU-pilE SOE 5’ oligonucleotide pairs.  The resulting deletion plasmid lacks the coding 
sequence from the fimU start codon to the pilE stop codon.  Oligonucleotide pairs fimU-pilE 5’/fimU-
pilE 3’ and fimU-pilE 3’/pilY1 3’ (Table 2.2) were used to confirm deletion of the pilY1 operon as 
previously described (29).  For routine passage, E. coli and P. aeruginosa were grown at 37°C in 
Luria Bertani (LB) medium.  The pMMB-based expression plasmids were maintained in P. 
aeruginosa with 150 µg/ml carbenicillin (Cb), except where noted. Bacterial growth in broth culture 
was assessed by optical density at 600 nm (OD600). 
Expression plasmid construction  
The open reading frame (ORF) of P. aeruginosa pilY1 and the entire pilY1 operon 
(fimUpilVWXY1Y2E, referred to as “fimU-pilE”) were amplified from chromosomal DNA from strain 
PAK and cloned into pMMBV2GW (pPa-pilY1 and pPa-fimU-pilE) using Gateway Technology 
(Invitrogen) as described previously (66).  Briefly, PCR fragments were tailed with attB1 and attB2 
sequences, cloned into the pDONR201 entry vector and then transferred to the destination vector 
(pMMBV2GW).  The pMMBV2GW plasmid is a version of the P. aeruginosa expression plasmid 
pMMBGW (66) in which the sequence of the -35 region of the tac promoter was changed from 
TTGACA to TTTACA, and the -10 region of the tac promoter was changed from TATAAT to 
CATTAT (M. Wolfgang and S. Lory, unpublished). These promoter region modifications were 
predicted to reduce the efficiency of transcriptional initiation at the tac promoter, allowing for 
reduced levels of expression.  The pilY1 ORF was PCR amplified using the 5’ pilY1-2 and 3’ pilY1-2 
oligonucleotide pair.  The entire pilY1 operon was PCR amplified using 5’ fimU and 3’ pilE 
oligonucleotides.  All expression plasmids were transferred to the appropriate PAK strain by 
conjugation (24) followed by selection on LB agar plates containing 150 µg/ml Cb and 25 µg/ml 
63 
 
irgasan. Unless otherwise noted, strains containing expression plasmids were grown in the presence 
of 20 µM (pPa-pilT) or 75 µM (pPa-pilY1 and pPa-fimU-pilE) isopropyl-β-D-thiogalactopyranoside 
(IPTG). 
Microscopy  
Transmission electron microscopy (TEM) was performed as described previously (63), with 
the exception that grids were placed on a drop of bacterial suspension at 22
o
C for 10 minutes and the 
samples were stained with an aqueous 0.5% ammonium molybdate solution for 10 minutes. 
Immunofluorescence (IF) microscopy was performed as described previously (62), except that the P. 
aeruginosa strains were grown until OD600 = 0.2 prior to incubating the bacteria on poly-L-lysine-
coated glass cover slips. P. aeruginosa pilin-specific antiserum (gift of E. C. Gotschlich, Rockefeller 
University) was used as a primary antibody for TFP labeling, followed by an Alexa Red-conjugated 
goat anti-rabbit IgG (Molecular Probes). 
Pilus Preparation  
To isolate TFP sheared from the bacterial surface, P. aeruginosa strains were inoculated for 
confluent growth on LB agar plates. For assays with plasmid-harboring strains, bacteria were grown 
on LB agar containing 30 µg/ml Cb and the indicated amount of IPTG. After incubation at 37
o
C for 
18 hours, bacteria were collected and suspended in 10 ml of 0.15 M NaCl and 0.2% (w/v) 
formaldehyde. The suspensions were vortexed for 1 minute and cells were removed by centrifugation 
at 12,000 × g for 5 minutes. The supernatant was transferred to a 15 ml glass Corex tube, adjusted to 
0.1 M MgCl2, and incubated at 4
o
C for 3 hours. Following centrifugation 12,000 × g for 5 minutes, 
the resulting pellet was washed and suspended in SDS-PAGE sample buffer, resolved on an 18% 
(w/v) polyacrylamide gel and visualized by GelCode Blue Stain (Pierce). The relative amount of pilin 
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monomer demonstrated by SDS-PAGE was used as an indicator of the abundance of TFP on the 
bacterial surface. 
Twitching motility assay  
P. aeruginosa strains were grown overnight at 37
o
C on LB agar plates and bacteria were stab-
inoculated to the bottom of 100 mm tissue culture-treated dishes (Corning) containing 5 ml LB plus 
1% (w/v) agar. For assays with plasmid-harboring strains, bacteria were grown in the presence of 30 
µg/ml Cb and the indicated amount of IPTG. Plates were incubated for 48 hours at 37
o
C in a 
humidified chamber. The zone of subsurface bacterial growth radiating from the point of inoculation 
was measured at 24 and 48 hours post-inoculation and reported as a rate (mm/hr) of twitching zone 
expansion. 
Western Blots  
Whole cell lysates for detection of pilin, PilY1, and PilT were prepared from bacteria grown 
in LB broth until OD600 = 1. Bacteria were collected by centrifugation and resuspended in 50 µl of 
SDS-PAGE sample buffer.  Samples were run on 18% (pilin and PilT) or 7.5% (PilY1) SDS-
polyacrylamide gels and transferred to nitrocellulose. Membranes were probed with the following 
primary antibodies:  PKL1 anti-pilin monoclonal antibody (68) (1:30,000 dilution, gift of Randall 
Irvin, University of Alberta), anti-PilT rabbit serum (1:30,000 dilution, gift of Katrina Forest, 
University of Wisconsin), or anti-PilY1 rabbit serum (1:4000 dilution).  PilY1-specific serum was 
generated in collaboration with Dr. Matt Redinbo (University of North Carolina-Chapel Hill) and 
Cocalico Biologicals.  A horseradish peroxidase (HRP)-conjugated goat anti-rabbit Ig (Rockland) was 
used as a secondary antibody at a dilution of 1:80,000 (PilY1 and PilT).  An HRP-conjugated goat 
anti-mouse Ig antibody (Promega) was used at a 1:40,000 for detection of the PKL1 anti-pilin 
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antibody. Blots were developed with enhanced chemiluminescence reagents (Millipore) and 
visualized by autoradiography. 
Binding and Cytotoxicity assays  
Binding of P. aeruginosa strains to A549 cells, as well as the associated cytotoxicity in these 
infections, was assessed as described previously (13).  Human airway epithelial (HAE) cell cultures 
were collected and grown on transwell membranes as described (23), with the exception that cells 
were grown in the described ALI media until 1 day prior to infection, when they were transferred to 
antibiotic-free ALI.  A plasmid that constitutively expresses GFP (pSMC21) (6) was transferred into 
PAK, and the indicated mutant strains, as previously described (24).  Successful GFP expression was 
determined by visual observation.  The subsequent GFP-expressing strains were grown in LB broth 
with 50 µg/ml Kanamycin until OD600 = 1.0, washed twice with sterile PBS, and resuspended in 1 ml 
of antibiotic-free ALI cell culture media to a concentration of 4x10
8
 cfu/ml.  HAE cultures were 
injured by lightly dragging a sterile 200 µl pipette tip across the apical cell surface, leaving a thin 
layer of exposed basal cells.  A total of 250 µl of each strain was added to the appropriate HAE 
culture at an approximate MOI of 1000.  After incubation at 37
o
C and 5% CO2 for 45 minutes, all 
HAE cultures were washed six times with pre-warmed antibiotic-free ALI media.  After the final 
wash, all media was removed from the surface of the HAE cultures.  Binding of GFP P. aeruginosa to 
the injury site was assessed visually and recorded using a Leica DMIRB Inverted Fluorescence/DIC 
microscope with black/white and color digital camera.  Phase contrast images of the infected cultures 
were taken in parallel in order to locate the site of injury.  After imaging, infected HAE cultures were 
fixed in a solution of 2% (w/v) Formaldehyde + 2% (w/v) Paraformaldehyde overnight, embedded in 
epon resin, and sectioned perpendicular to the injured section of the HAE culture.  Semi-thin sections 
from the center of the cell culture preparation were stained with Richardson’s stain to allow for 
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successful distinction of single bacteria and HAE cells.  Representative sections were visualized by 
light microscopy and imaged.   
Discussion 
For many gram-negative pathogens, TFP play an important role in host infection and 
colonization.  While these organelles are associated with a variety of species-specific phenotypes, 
their primary function appears to involve the presentation of adhesive molecules or epitopes that 
interact with receptors on host cells and tissue.  The best example of a TFP associated adhesin is the 
PilC protein of eisseria gonorrhoeae and . meningitidis. Purified PilC is capable of binding to host 
cells and can competitively blocks epithelial cell adherence of both piliated gonococci and 
meningococci (33, 46).  In addition to their role in adherence, TFP expressed by a number of 
organisms are retractile (37). When coupled with adherence to a host receptor, retraction can facilitate 
intimate or tight adherence (39). In addition, rounds of extension and retraction can drive surface 
motility (twitching motility), which can facilitate bacterial spread across abiotic surfaces as well as 
dissemination within host cells and tissue (39, 54). Interestingly, PilC has been shown to antagonize 
pilus retraction, suggesting a possible mechanistic link between the adhesin-receptor interaction, 
intimate attachment and pilus-dependent motility (39, 64). While the pilus-associated adhesin in 
eisseria species has been well characterized, little is currently known about TFP-associated adhesins 
in other pathogenic bacteria. Here we describe the dual role of Pseudomonas aeruginosa PilY1 in 
TFP biogenesis and adherence.    
With the exception of pathogenic eisseria, the adhesive component of TFP produced by 
other species is unknown or poorly characterized. In P. aeruginosa, an exposed disulphide loop in the 
C-terminus of the pilin monomer is believed to mediate TFP adhesion to exposed asialo-GM1 and 
asialo-GM2 receptors on the apical surface of target host cells.  Recently, studies have questioned the 
direct role of pilin in TFP-mediated adherence.  Emam et al. demonstrated a lack of binding between 
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piliated P. aeruginosa to either asialo-GM1 or asialo-GM2 (21).  This data, along with the prior PilC 
work in eisseria, led us to examine the role of PilY1, a protein with limited homology to eisseria 
PilC, in P. aeruginosa TFP-dependent adherence to human epithelial cells.   
We demonstrate the requirement of PilY1 for TFP-mediated adherence to exposed basolateral 
surfaces of primary human epithelial cells (Fig. 2.8 and 2.9).  P. aeruginosa is only able to bind to 
the airway epithelium when PilY1 is present in the TFP fraction.  Binding is abolished in the absence 
of pilus fibers or when PilY1-lacking TFP are produced (pilY1, pilT).  While this does not rule out the 
contribution of pilin to adherence, it does indicate the importance of PilY1 in the process and points 
to a high affinity host cell receptor, which is only present on the basolateral surface of well-
differentiated cells. 
It is currently unclear why our wild type strain displays relatively poor adherence to A549 
cells (Fig. 2.6). However, P. aeruginosa is known to have poor binding efficiency to mammalian 
cells when they are grown as undifferentiated monolayers (13, 35, 66). Despite the low level of 
adherence of P. aeruginosa to undifferentiated cell lines, a clear requirement for TFP has been shown 
(Fig. 2.6). Surprisingly, adherence in these systems also requires pilus retraction, as the binding 
efficiency of a hyperpiliated pilT mutant is indistinguishable from that of non-piliated strains (Fig. 
2.6) (13). This poor binding efficiency could be due to the absence of a critical epithelial cell 
receptor, or in the case of the pilT mutant, the lack of pilus retraction. It has been proposed that TFP 
are likely to have multiple mechanisms for adhering to surfaces, including reversible adherence and 
high-affinity adherence (8). Reversible adherence is likely to be non-specific and necessary for 
twitching motility. Such that, following extension, the pilus can tether to a variety of surfaces and 
provide an anchor for retraction. This interaction needs be relatively non-specific, so that the bacteria 
can move across a variety of surfaces, and of low affinity so that adherence is reversible. It is 
conceivable that low affinity adherence to undifferentiated cell lines involves the DSL region of pilin 
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and that subsequent pilus retraction may facilitate additional interactions between the bacteria and 
host cell surface. This may account for the discrepancy between our results with A549 monolayers 
and injured HAE cell cultures.  
Previously, Alm et al. defined a general localization of PilY1 to the pilus fraction of a wild 
type strain, with a low level of protein in the membrane fraction (1).  While our findings are in 
agreement with published data, we have extended the observation to show that additional genes in the 
pilY1 operon (FimU, PilV, PilW, PilX, and PilE), which show a high degree of homology with N-
terminal domain of pilin, are required for localization of PilY1 to TFP fraction (Fig. 2.5). Similar 
results were seen for eisseria PilC, which also requires the expression of pilin-like proteins in order 
to associate with the pilus fraction (62).  While our data does not prove that PilY1 is part of the pilus 
fiber, it does indicate the localization of PilY1 is specific to the pilus fraction.  The P. aeruginosa 
pilin-like proteins may be required to trafficking PilY1 to the pilus fraction or may be part of a PilY1 
containing complex that is associated with the pilus fiber.  In either case, localization of PilY1 to the 
pilus fraction is consistent with its role as a TFP-associated adhesin. 
In addition to its role in TFP-mediated adherence, PilY1 also appears to play a role in 
formation of the pilus fiber.  Initial experiments indicated PilY1 might be essential for TFP 
biogenesis.  When pilY1 is inactivated in a wild type background, we are unable to detect TFP fibers 
(Fig. 2.1, 2.2 and 2.3).  However, when pilus retraction is abolished by inactivating pilT (Fig. 2.4), 
we are able to restore detectable TFP in a pilY1 mutant (Fig. 2.1, 2.2 and 2.3).  Therefore, PilY1 
appears to be conditionally required for TFP biogenesis. 
The mechanism used by PilY1 to affect TFP biogenesis is currently unknown.  However, we 
can define a potential mechanism using what is known about TFP in P. aeruginosa, as well as data 
from PilC in eisseria.  PilT is an ATPase that is required for retraction of TFP in P. aeruginosa, 
eisseria, and other gram-negative bacteria (37).  When pilT is inactivated, pili are unable to retract 
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and the resulting mutants are unable to twitch (Fig. 2.4) (38, 61).  Given that TFP biogenesis is 
restored in a pilY1 mutant when pilT is inactivated, the role of PilY1 in the biogenesis process appears 
to center around counteracting or antagonizing PilT-driven pilus retraction.  This hypothesis is 
supported by data from PilC in eisseria.  Like PilY1, PilC is required for TFP biogenesis in a wild 
type background but not in a pilT mutant background (31, 47, 64).  Further analysis in eisseria 
described PilC as an inhibitor of PilT-driven fiber retraction rather than an essential factor in fiber 
formation (39).  Specifically, efficient TFP assembly occurs, regardless of the amount of PilC present, 
in strains lacking the pilus retraction protein.  In an adherence model, where pilus extension and 
retraction are sequentially observed, down regulation of pilC correlates with pilus retraction. Thus, 
pilus retraction accounts for the apparent defect in TFP biogenesis seen in pilC mutants.  Given our 
data describing the effect of a pilT inactivation on the TFP biogenesis defect of a pilY1 mutant, as 
well as the homology between PilC and PilY1, it is reasonable to predict that PilY1 acts as an 
inhibitor of PilT-driven fiber retraction rather than an as essential factor in fiber assembly. 
Interestingly, the homology between PilY1 and eisseria PilC it is limited to the C-terminal 
half of these proteins.  We also find similar C-terminal homology between PilY1 and proteins in other 
bacteria, which are required for TFP biogenesis (data not shown). The size of PilY1 (approximately 
117 kD) and other related proteins indicates the potential for two different functional domains.  A 
similar architecture exists for hemagglutinins, which are large proteins comprised of both structural 
and adhesive domains (17).  Given the apparent dual roles of both PilY1 and PilC in TFP biogenesis 
and adherence, it is plausible that the C- and N-terminal portions of these proteins play different 
functional roles.  For instance, the C-terminal half of PilY1 may be involved in TFP biogenesis, while 
the N-terminal half would be responsible for adherence.  If the N-terminus is involved in adherence, it 
would make sense that it would diverge in sequence to match the host and tissue tropism of the 
individual pathogen  This hypothesis is supported by data from Morand et al., who demonstrated that 
the adhesion-promoting region of PilC is located in the N-terminal part of the molecule (40). 
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Therefore it appears PilY1 and PilC are members of a family of bi-functional proteins that are defined 
by their C-terminal homology, divergent N-terminal domains, and function in biogenesis and 
adherence of Type IV pili.   
In summary, we have demonstrated that PilY1 plays an important and potentially central role 
in the function of P. aeruginosa TFP. Localization of PilY1 to the pilus fraction may provide a means 
for both antagonizing fiber retraction and providing adhesive properties to the organelle. Further, we 
have described a model of infection by which PilY1 is required for robust adherence to exposed basal 
cells and basolateral surfaces of injured HAE cell cultures. These results demonstrate the utility of 
HAE cell cultures in studying the early steps of P. aeruginosa infections.  Additionally, we believe 
that PilY1 is a member of a larger family of bi-functional proteins that many confer similar properties 
to TFP expressed by a wide range of gram-negative pathogens.  Though more work is required to 
elucidate the specific mechanisms controlling pilus retraction and adherence, we believe that 
understanding the function of PilY1 will provide new insight into these complex and dynamic 
processes.  
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Table 2.1.  List of Strains and Plasmids 
 
Strain/plasmid Description/relevant characteristics
*
 Source or reference 
 
 PAK wild type D. Bradley 
 PAKpilA Non-polar pilA deletion in PAK Kagami et al. (1998) 
 PAKpilT Non-polar pilT deletion in PAK Sundin et al. (2002)
 PAKpscC Non-polar pscC deletion in PAK Wolfgang et al. (2003) 
 PAKpilY1 Non-polar pilY1 deletion in PAK This study 
 PAKpilY1, pilT Non-polar pilY1 and pilT deletion in PAK This study 
 PAKfimU-pilE Non-polar deletion of fimUpilVWXY1Y2E in PAK This study 
  PAKfimU-pilE, pilT Non-polar deletion of fimUpilVWXY1Y2E and pilT in PAK This study 
  
Plasmid 
 pDONR201 Gateway cloning vector; Kmr   Invitrogen 
 pEXGm∆pilY1 Suicide vector containing pilY1 deletion allele; Gmr   This study 
 pEXGm∆fimU-pilE Suicide vector containing fimUpilVWXY1Y2E deletion allele; Gmr This study 
 pMMB67EH Empty P. aeruginosa expression vector; Apr    Furste et al. (1986) 
 pMMBGW Gateway-adapted version of pMMB67EH; Apr     Wolfgang et al. (2003) 
 pSMC21 Constitutive expresser of GFP; Kmr     Bloemberg et al. (1997) 
 pMMBV1GW pMMBGW with altered -35 sequence; Apr    This study 
 pMMBV2GW pMMBV1GW with altered -10 sequence; Apr    This study 
 pPa-pilT P. aeruginosa pilT encoded by pMMBV1GW; Apr    This study 
 pPa-pilY1 P. aeruginosa pilY1 encoded by pMMBV2GW; Apr    This study 
 pPa-fimU-pilE P. aeruginosa fimUpilVWXY1Y2E encoded by pMMBV2GW; Apr This study 
 
*
Ap
r
, ampicillin resistance marker; Km
r
, kanamycin resistance marker; Gm
r
, gentamicin resistance marker 
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Table 2.2.  List of Primer Sequences 
 
 
Primer Sequence  
 
pilY1 5’  5’-TACAAAAAAGCAGGCTGGACGCTTCGCCATGATGTTCCTG-3’  
pilY1 3’  5’-TACAAGAAAGCTGGGTAACATTACCTTCTCGATGCCCAAG-3’  
pilY1 SOE 5’ 5’-CCTCGCATGAAATCGGTACTCCACGAATTCGGGGTCGTGGGACTCGAAATCCGA-3’ 
pilY1 SOE 3’ 5’-TCGGATTTCGAGTCCCACGACCCCGAATTCGTGGAGTACCGATTTCATGCGAGG-3’ 
5’ pilY1-2  5’-TCGAGGAGGATATTCATGAAATCGGCACTCCACCAG-3’  
3’ pilY1-2  5’-CAAGAAAGCTGGGTTTCAGTTCTTTCCTTCGATGGG-3’  
fimU-pilE 5’ 5’-TACAAAAAAGCAGGCTGTCAACAGGCCGATGACGCCAGCG-3’  
fimU-pilE 3’ 5’-TACAAGAAAGCTGGGTGAACTCGATCAGGTGCCGAACAACG-3’ 
fimU-pilE SOE 5’ 5’-GACCCCCTGGAGCAACCGCATGTCTGAAACGAAAGAGCCCCTCTACGAG-3’ 
fimU-pilE SOE 3’ 5’-CTCGTAGAGGGGCTCTTTCGTTTCAGACATGCGGTTGCTCCAGGGGGTC-3’ 
5’ fimU  5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTCGAGGAGGATATTCATGTCATATCG-3’ 
3’ pilE  5’-GGGGACCACTTTGTACAAGAAAGCTGGGTTTCAGCGCCAGCAGTCGTTGACGGT-3’
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Figure 2.1.  Inactivation of pilT suppresses the TFP biogenesis defect of a pilY1 mutant (TEM).  
Pili of the indicated strains were visualized by Transmission Electron Microscopy (TEM).  Visible 
pilus fibers are absent in a pilY1 mutant, similar to what is seen with the negative control (pilA).  Wild 
type levels of pilus fibers are restored when pilY1 is complemented with plasmid-expressed pilY1 
(pilY1 (pPa-pilY1)), indicating the TFP biogenesis defect is specific to the pilY1 mutation.  Visible 
pilus fibers are also restored in a pilY1 mutant when pilT is inactivated in the same strain (pilY1, pilT), 
indicating PilY1 is not required for essential biog
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Figure 2.2.  Inactivation of pilT suppresses the TFP biogenesis defect of a pilY1 mutant (IF).  Pili 
of the indicated strains were visualized by immunofluorescence microscopy.  The pilY1 mutant has no 
detectable pilus fibers, and appears similar to the negative control (pilA).  Detectable fibers are 
restored to near wild type levels when pilY1 is complemented in trans with plasmid-expressed pilY1 
(pilY1 (pPa-pilY1)), indicating the TFP biogenesis defect is specific to pilY1.  Most importantly, 
detectable pilus fibers are restored in a pilY1 mutant when pilT is inactivated in the same strain 
(pilY1,pilT), indicating PilY1 is not required for essential biogenesis of the pilus fiber.   
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Figure 2.3.  PilY1 is necessary for TFP biogenesis, but not required for pilin expression or 
assembly.  Coomassie Blue-stained gel showing the relative abundance of recovered pilin in the pilus 
fractions (A).  Western blot of separated pilus fractions probed with PilY1-specific antiserum (B). 
Whole cell lysates separated by SDS-PAGE and probed with pilin-specific (C), PilY1-specific (D) or 
PilT-specific (E) antiserum by Western blotting.  Western blot of pilT expression in whole cell lysates 
is included as a control (E).  Pilin is absent in a sheared pilus fraction of a pilY1 mutant, but is 
restored when pilT is deleted in the same strain (pilY1,pilT) (A).  The TFP biogenesis defect of a 
pilY1 mutant is NOT associated with changes in pilA expression within the cell (C).  In strains where 
PilY1 is present in whole cell lysates (D), it is also found in the sheared pilus fraction (B) if pilus 
fibers are present.     
 
 
 
 
 
 
 
77 
 
 
 
Figure 2.4.  Lack of TFP biogenesis results in a twitching motility defect in a pilY1 mutant.  
Recorded rates of twitching zone expansion over a period of 24 hours are described above.  The pilY1 
mutant is as defective for twitching motility, similar to the negative control (pilA) and a pilT mutant.  
The lack of twitching motility in a pilT mutant is due to the absence of retractile pili.  However the 
twitching defect of a pilY1 mutant is most likely due to the absence of pilus fibers on the surface of 
the cell.  Twitching in a pilY1 mutant is restored to wild type levels when pilY1 is complemented by 
plasmid expressed PilY1 (pPa-pilY1), indicating the defect is specific to the pilY1 mutation.  The grey 
bars describe the mean of three replicates (n=3) per strain and condition, with standard deviation per 
mean represented by the associated error bars.  The values for the indicated strains (*) are 
significantly different (p<0.001) when compared pair wise to the wild type strain.   
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Figure 2.5.  Localization of PilY1 to the sheared pilus fraction requires additional genes on the 
pilY1 operon.  Coomassie Blue-stained gel showing the relative abundance of recovered pilin in the 
pilus fractions (A).  Western blot of separated pilus fractions probed with PilY1-specific antiserum 
(B).  Whole cell lysates separated by SDS-PAGE and probed with either pilin-specific (C) or PilY1-
specific (D) antiserum by Western blotting.  Deletion of the pilY1 operon (fimU-pilE) abolishes TFP 
biogenesis (A), but does not affect pilin expression (C).  The defect in TFP biogenesis can be 
suppressed by inactivation of pilT  (fimU-pilE, pilT) (A).  Complementation of the piliated fimU-pilE, 
pilT mutant with plasmid-encoded PilY1 (pPa-pilY1)(D) does not restore localization of PilY1 to the 
pilus fraction (B).  Only complementation the entire pilY1 operon (pPa-fimU-pilE) restores 
localization of PilY1 to the pilus fraction (B), indicating one or more of the genes located on the pilY1 
operon (fimUpilVWXY1Y2E) are required for successful localization of PilY1 to the pilus fraction.   
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Figure 2.6.  PilY1 is necessary for adherence and cytotoxicity of A549 cells in vitro.  Levels of 
wild type and mutant binding to (white bars) and cytotoxicity of (grey bars) A549 cells are shown.  
The pilY1 mutant is defective for both binding and cytotoxicity.  This defect is reversible upon 
complementation with plasmid-expressed PilY1, which restores A549 binding and cytotoxicity to 
near wild type levels.  However, the binding and cytotoxicity defect remains in strains that express 
non-retractile pilus fibers in the presence (pilT) and absence (pilY1,pilT) of PilY1.  The type III 
secretion mutant (pscC) is included as a control for cytotoxicity.  The bars describe the mean of three 
replicates (n=3) per strain and condition, with standard deviation per mean represented by the 
associated error bars.  The values for the indicated strains (*) are significantly different (p<0.001) 
when compared pair wise to the values for the wild type strain. 
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Figure 2.7.  Pseudomonas aeruginosa requires TFP to infect well-differentiated human airway 
epithelial (HAE) cultures.  Cross-sections of HAE cultures infected with wild type, pilA, and pscC 
strains.  Representative images of each infection were taken at 3, 6, and 12 hours post infection.  Wild 
type P. aeruginosa rarely adhered to the ciliated apical cell surface but local infection foci could be 
detected after 3 hours.  The wild type strain interacted efficiently with the basolateral surfaces of 
ciliated cells and the entire surface of undifferentiated basal cells.  Bacterial adherence was associated 
with host cell rounding and detachment. By 12 hours, the wild type infection appeared to spread 
intercellularly to encompass the entire HAE culture. In contrast, neither the non-piliated pilA mutant 
nor the type III secretion mutant (pscC) ever spread beyond the airway surface liquid. 
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Figure 2.8.  PilY1 is required for adherence of Pseudomonas aeruginosa to injured HAE cells.  
HAE cultures were imaged (top-down) by fluorescence microscopy after 45 minutes of infection with 
GFP-expressing strains. Wild type P. aeruginosa and the piliated pilT mutant attached efficiently to 
the damaged tissue and showed little interaction with the surrounding intact epithelium. The non-
piliated (pilY1) and piliated (pilY1, pilT) mutants did not adhere to the damaged tissue and were 
indistinguishable from the non-piliated control mutant (pilA). For non-adherent strains, tissue damage 
was confirmed by examining the HAE cultures by both fluorescence and light microscopy. 
Adherence was restored for both the non-piliated and piliated pilY1 mutants following 
complementation with plasmid-expressed PilY1 (pPa-pilY1). 
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Figure 2.9.  PilY1 is required for adherence of Pseudomonas aeruginosa to exposed basal cells of 
injured HAE cell cultures.  Infected HAE cultures from Figure 2.8 were fixed and sectioned, with 
exposed basal cells from the injury site are shown.  Piliated (pilY1) and non-piliated (pilY1, pilT) 
strains were defective for binding to exposed basal cells at the injury site.  Adherence was restored for 
both the non-piliated and piliated pilY1 mutants following complementation with plasmid-expressed 
PilY1 (pPa-pilY1), or in the strain that expresses pilus containing PilY1 (pilT). 
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CHAPTER 3 
 
 
COCLUSIO 
 
 
Pseudomonas aeruginosa is a versatile, opportunistic pathogen that has emerged as a major 
source of hospital-acquired infections and the main cause of morbidity and mortality in persons 
afflicted by CF (23, 36).  The ability of this organism to cause life threatening infections is due to its 
intrinsic high resistance to most antibiotics and its capacity to express a wide range of virulence 
factors.  These factors include extracellular toxins secreted by type II and type III secretion systems, 
quorum sensing, biofilm formation, and mutational adaptation leading to alginate production.  While 
acute and chronic P. aeruginosa infections involve fundamentally different bacterial lifestyles and 
distinct sets of virulence factors, both types of infection require initial colonization of the host, a 
process that is mediated by TFP-dependent attachment of bacteria to host cells and tissue.  Despite the 
important role of TFP in pathogenesis, the molecular detail of host attachment and the nature of the 
pilus adhesin are currently unclear.  The purpose of this thesis was to characterize the role of PilY1, a 
TFP associated protein, in mediating bacterial-host interactions.  
TFP are polymeric surface fibers used by a variety of bacteria to mediate attachment to host 
cells (25).  Pilus fibers mediate intimate interactions between P. aeruginosa and host cells, and 
facilitate contact-dependent type III secretion of toxins (6, 7, 39, 45).  In addition to facilitating host 
attachment, TFP in P. aeruginosa contribute to biofilm formation, and drive a specialized form of 
movement known as twitching motility, which contributes to bacterial dissemination (4, 6, 20, 26, 29, 
35, 42).  Previous experiments indicate that the disulfide loop (DSL) region of pilin, exclusively 
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exposed at the tip of the pilus filament, serves as the adhesive epitope for binding of the pilus fiber to 
the GalNAcβ1-4Gal moiety present on asialylated glycosphingolipids (GSLs) (3, 9, 10, 12, 14, 16, 
22).  Evidence for direct binding of pilin to asialylated GSLs is primarily derived from studies using 
purified pilus fibers. More recent experiments demonstrate that TFP producing strains of P. 
aeruginosa do not bind to asialylated GSLs (11).  In fact, most studies report relatively poor binding 
of piliated P. aeruginosa strains (1-5 bacteria/cell) to the apical surface of cultured cells (21), despite 
the fact that asialylated GSLs are predominantly presented on the apical surface (38).  In contrast, 
several studies have reported the preferential binding of P. aeruginosa to the basolateral surfaces of 
cultured epithelial cells, or damaged areas of cell culture monolayers where basolateral surfaces are 
exposed (13, 21).  These results strongly suggest that asialylated GSLs are not the primary receptor 
for TFP-dependent binding and indicate that another component of TFP may serve as the adhesin.  
Using a heterologous expression system, we recently showed that eisseria gonorrhoeae could 
assemble surface TFP composed of P. aeruginosa pilin (43).  Surprisingly, the bacteria were unable 
to bind to primary human epithelial cells in the absence of the gonococcal TFP-associated adhesin 
PilC2.  However, gonococcal binding could be restored when P. aeruginosa pilin was co-expressed 
with gonococcal PilC.  In this system, PilC was able to associate with the heterologous fibers 
containing P. aeruginosa pilin. These results strongly suggest that P. aeruginosa pilin does not have 
intrinsic adherence properties and that other P. aeruginosa TFP-associated proteins are necessary for 
adherence.  
The lack of clear data supporting a direct involvement of pilin in P. aeruginosa adherence 
prompted our search for a TFP-associated adhesin.  In Chapter 2, we describe the characterization of 
P. aeruginosa PilY1, a previously identified TFP-associated protein, with limited homology to the C-
terminal region of gonococcal PilC2.  Specifically, we show that PilY1 is conditionally required for 
TFP biogenesis and that it may antagonize pilus retraction.  Second, we show that PilY1 specifically 
associates with the TFP fraction of P. aeruginosa, and that localization requires a set of genes with 
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homology to pilin (“pilin-like”). Lastly, we demonstrate that association of PilY1 with the 
extracellular pilus fraction is necessary for adherence of P. aeruginosa to injured human airway 
epithelial (HAE) cells, indicating a potential role for PilY1 as a TFP-associated adhesin. 
These findings represent a paradigm shift in our view of P. aeruginosa pathogenesis and have 
broader implication for the mechanism of TFP-mediated adherence by other gram-negative 
pathogens. Despite their limited homology, P. aeruginosa PilY1 and eisseria PilC proteins appear 
to be members of a large family of proteins found in a number of TFP-expressing bacteria.  We 
hypothesize that other members of this family are likely to be required for TFP-mediated adherence to 
host cells.  This hypothesis is supported by recent data from the gram-negative pathogen Kingella 
kingae.  K. kingae expresses TFP that are essential for adherence to both synovial and respiratory 
epithelial cells (19).  The K. kingae genome encodes two PilY1/PilC homologs. Mutants lacking 
either gene show reduced adherence and a double mutant lacking both pilY1/pilC alleles is unable to 
adhere to host cells, suggesting the these proteins may function as adhesins (19).  However, the direct 
involvement of K. kingae PilY1/PilC proteins in adherence remains to be determined, given that the 
double mutant fails to produce pili.  The defect of pilus production seen in mutants lacking 
PilY1/PilC homologs represents a substantial hurdle in assigning a definitive and direct role in 
adherence. The fact that biogenesis can be restored in these mutants by eliminating the easily 
identifiable pilus retraction protein (PilT) suggests a general strategy for bypassing the biogenesis 
defect.  The application of a similar strategy is likely to be useful in other systems. 
While our findings have identified a potentially key protein (PilY1) in the function of TFP in 
P. aeruginosa, many questions remain unanswered.  First, it is well established that many 
components of the TFP biogenesis machinery are highly conserved among phylogenetically distant 
gram-negative organisms. If PilY1 and PilC represent a general family of TFP-associated adhesins, 
why are their primary sequences, and the sequences of other family members, so divergent?  As 
92 
 
mentioned above, homology between P. aeruginosa PilY1 and . gonorrhoeae PilC (as well as other 
members of this family) is limited to the C-terminal half of the protein.  Is it possible that the N- and 
C-terminus of these proteins represent different functional domains?  We hypothesize that the 
conserved C-terminal half of PilY1 is responsible for TFP biogenesis or “anti-retraction”.  
Consequently, we hypothesize that the N-terminal half of PilY1/PilC proteins is involved in 
adherence and has diverged in sequence according to the specific tissue and host tropism of the 
individual pathogen.  This hypothesis is supported by data from eisseria meningitidis.  In this gram-
negative pathogen, there are two pilC alleles; either is sufficient to support pilus assembly.  Yet, only 
PilC1 is able to support TFP-mediated adherence (28).  When studies were performed to identify the 
regions of PilC1 required for adherence, using PilC1-PilC2 hybrids, it was demonstrated that the 
adhesion-promoting domain of PilC1 is located within the N-terminal region of the protein (28).  
Further, regardless of the combination of PilC1- and PilC2-specific regions, all strains were piliated, 
suggesting that PilC-mediated adherence and PilC-dependant TFP biogenesis involve distinct regions 
of the protein (28).  However, even with this supporting evidence, our hypothesis is speculative and 
requires further work in P. aeruginosa to determine whether there is a functional difference in the C- 
and N-terminal domains of PilY1.      
The mechanism used by PilY1, and related proteins, to control TFP biogenesis is currently 
unknown, but it deserves substantial consideration.  Without PilY1 in the pilus fraction, we are unable 
to detect pilus fibers on the surface of the bacterium.  It is possible that the level of pilY1 expression, 
and subsequent levels of PilY1 in the cell, may function to enhance extension (high PilY1 levels) or 
retraction (low PilY1 levels) of the pilus fiber in response to environmental cues.  Support for this 
model comes from the regulation of the pilY1 operon by both cAMP/Vfr and the 2-component 
regulatory system AlgZ/R (2, 18).  In particular, phosphorylation of AlgR is required for successful 
twitching motility in P. aeruginosa (2).  Twitching motility only occurs due to the successful 
extension and retraction of TFP from the surface of the bacterium (37).  Therefore, levels of pilY1 
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expression may control extension and retraction of the pilus fiber.  This phenomenon appears to be 
specific to the pilY1 operon, as the level of pilA (pilin) expression is unchanged in a Vfr mutant (18), 
and RT-PCR analysis of surface grown P. aeruginosa suggests the pilY1 operon fully accounts for the 
effect of AlgR on TFP expression and biogenesis (2).  This would suggest that there are conditions 
where it is favorable for the bacterium to modulate the level of PilY1, and associated proteins, 
independent of the rest of the TFP biogenesis machinery.  Supporting this theory is data 
demonstrating positive regulation of the TFP-associated adhesin in . meningitidis (PilC1) by contact 
of the bacteria to viable host cells (40).  Additionally, downregulation of PilC in . meningitidis is 
associated with pilus retraction (27).  Taken together, this data suggests P. aeruginosa controls pilus 
extension (biogenesis) and retraction by modulating the amount of PilY1 present in the cell.  
While the control of PilY1 levels may be a general mechanism for altering pilus dynamics 
under certain conditions, our results suggest that the expression of PilY1 is required for host 
adherence.  The fact that PilY1 appears to function as both an adhesin and a biogenesis factors 
implies that these two functions may be mechanistically linked.  We propose that during colonization, 
pilus-associated PilY1 initially binds to its host receptor, tethering the bacteria to the surface of host 
cells. However, given the shear forces encountered by the bacteria during infection, and the fact that 
TFP are brittle structures, tethered bacteria are likely to detach.  Subsequent retraction would allow 
the bacteria to intimately interact with the host cells.  Contact-dependent TFP retraction has been 
documented to occur in . meningitis following attachment to host cells (27).  Hypothetically, the 
binding of PilY1 to its cognate host receptor could alter the flexibility of the filament.  While 
currently undocumented, it is possible that the TFP filament rotates during polymerization, a 
phenomenon that has been recently described for conjugative pili (5).  Attachment of the pilus to a 
fixed surface or receptor could restrict rotation and cause a switch in polymerization dynamics 
resulting in retraction.  Similarly, attachment of PilY1 to its receptor may restrict pilus extension, 
generating a change in force, which then favors retraction.  Experiments with lazer tweezers have 
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shown that the application of external force on gonococcal pilus fibers can drive the switch between 
extension and retraction (24).  Alternatively, the interaction between PilY1 and its receptor could alter 
PilY1 interaction with the pilus resulting in a subtle change in the conformation of pilin. This 
conformational change could be propagated through the entire pilus fiber, resulting in retraction and a 
closer interaction between P. aeruginosa and the host cell.  Similar long range interactions have been 
documented for actin, where the binding of gelsolin to the growing or barbed end of the actin filament 
results in a conformational change in actin protomers that is propagated through-out the filament (31). 
The data presented in Chapter 2 indicates the localization of PilY1 to the pilus structure 
requires the expression of pilin-like proteins from the pilY1 operon.  However, it is unclear if all or 
only certain combinations of these proteins are required for successful PilY1 localization.  
Regardless, it appears that pilin-like proteins can integrate into the pilus at low levels and may be 
distributed at regular intervals along the length of the fiber (15).  This may provide a mechanism for 
the association of PilY1-like proteins at similar discrete intervals. As such PilY1 could antagonize 
retraction by stabilizing the elongating pilus incrementally.  It has been postulated that extension and 
retraction may occur by a ratchet like mechanisms (44), where the fiber is built and retracted in 
blocks or segments.  The length of these segments may be determined by the PilY1 interval. Such a 
model is consistent with the stepwise extension and retraction of TFP that has been directly visualized 
and measured using laser tweezers (24, 37).  A more thorough understanding of TFP fiber structure 
and the distribution of minor proteins within and along the pilus fiber shaft will provide important 
clues as to the mechanisms controlling pilus dynamics.  
Lastly, if PilY1 is the TFP-associated adhesin in P. aeruginosa, what is the corresponding 
receptor on the surface of host cells? Given the data presented, the PilY1 receptor is likely to be 
located on the basolateral surface of well-differentiated epithelial cells or may be upregulated for 
expression due to tissue injury or stress.  Currently there is no candidate, other than asialo-GM1/GM2, 
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for a P. aeruginosa TFP receptor.  Interestingly, exposure of a basolateral receptor may require prior 
tissue damage. Such a model is consistent with the propensity of P. aeruginosa to infect hosts with 
injured or damaged tissue (8, 30, 33, 34, 46).  Damage could occur from a prior medical condition, 
mechanical abrasion due to the use of catheters and ventilators (33), serious burns or other wounds, 
inflammation or from prior exposure to a variety of inhaled and infectious agents such as 
Haemophilus influenza (17) or P. aeruginosa itself (1, 41).  Consistent with this hypothesis, it is well 
documented that P. aeruginosa can only cause eye infections following abrasion of the corneal 
epithelium (32).  Identification of PilY1 as the TFP-associated adhesin is likely to expedite the search 
for the P. aeruginosa host receptor. Specifically, purified PilY1 protein would provide a useful 
reagent for cross-linking and pull-down experiments designed to identify potential interacting host 
proteins. 
The work represented in this thesis represents only the tip of the iceberg in understanding the 
early events in the pathogenesis of P. aeruginosa infection. Future studies are necessary to elucidate 
the mechanism of PilY1-dependant pilus retraction, to identify components of TFP that are required 
for PilY1-pilus associations, and to confirm the direct involvement of PilY1 in host adherence.  Our 
findings, combined with studies in pathogenic eisseria, suggest that PilY1 and PilC are part of a 
larger family of proteins that have a bi-functional role in TFP biogenesis and host adherence. This 
family of proteins is likely to play a vital role in the pathogenesis of other gram-negative infections 
and may represent a conserved and novel target for anti-infective therapies. 
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